<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2018-01-31" version="227">
<accession>Q09472</accession>
<accession>B1AKC2</accession>
<name>EP300_HUMAN</name>
<protein>
<recommendedName>
<fullName>Histone acetyltransferase p300</fullName>
<shortName>p300 HAT</shortName>
<ecNumber evidence="89 91 108">2.3.1.48</ecNumber>
</recommendedName>
<alternativeName>
<fullName>E1A-associated protein p300</fullName>
</alternativeName>
<alternativeName>
<fullName>Histone butyryltransferase p300</fullName>
<ecNumber evidence="78">2.3.1.-</ecNumber>
</alternativeName>
<alternativeName>
<fullName>Histone crotonyltransferase p300</fullName>
<ecNumber evidence="101">2.3.1.-</ecNumber>
</alternativeName>
<alternativeName>
<fullName>Protein propionyltransferase p300</fullName>
<ecNumber evidence="78">2.3.1.-</ecNumber>
</alternativeName>
</protein>
<gene>
<name type="primary">EP300</name>
<name type="synonym">P300</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Genes Dev." volume="8" first="869" last="884">
<title>Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.</title>
<authorList>
<person name="Eckner R."/>
<person name="Ewen M.E."/>
<person name="Newsome D."/>
<person name="Gerdes M."/>
<person name="Decaprio J.A."/>
<person name="Lawrence J.B."/>
<person name="Livingston D.M."/>
</authorList>
<dbReference type="PubMed" id="7523245"/>
<dbReference type="DOI" id="10.1101/gad.8.8.869"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT PRO-2223</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Nature" volume="402" first="489" last="495">
<title>The DNA sequence of human chromosome 22.</title>
<authorList>
<person name="Dunham I."/>
<person name="Hunt A.R."/>
<person name="Collins J.E."/>
<person name="Bruskiewich R."/>
<person name="Beare D.M."/>
<person name="Clamp M."/>
<person name="Smink L.J."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Buck D."/>
<person name="Burgess J."/>
<person name="Burrill W.D."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chen Y."/>
<person name="Clark G."/>
<person name="Clegg S.M."/>
<person name="Cobley V.E."/>
<person name="Cole C.G."/>
<person name="Collier R.E."/>
<person name="Connor R."/>
<person name="Conroy D."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Cox A.V."/>
<person name="Davis J."/>
<person name="Dawson E."/>
<person name="Dhami P.D."/>
<person name="Dockree C."/>
<person name="Dodsworth S.J."/>
<person name="Durbin R.M."/>
<person name="Ellington A.G."/>
<person name="Evans K.L."/>
<person name="Fey J.M."/>
<person name="Fleming K."/>
<person name="French L."/>
<person name="Garner A.A."/>
<person name="Gilbert J.G.R."/>
<person name="Goward M.E."/>
<person name="Grafham D.V."/>
<person name="Griffiths M.N.D."/>
<person name="Hall C."/>
<person name="Hall R.E."/>
<person name="Hall-Tamlyn G."/>
<person name="Heathcott R.W."/>
<person name="Ho S."/>
<person name="Holmes S."/>
<person name="Hunt S.E."/>
<person name="Jones M.C."/>
<person name="Kershaw J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C.F."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Martyn I.D."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L.H."/>
<person name="Mccann O.T."/>
<person name="Mcclay J."/>
<person name="Mclaren S."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mortimore B.J."/>
<person name="Odell C.N."/>
<person name="Pavitt R."/>
<person name="Pearce A.V."/>
<person name="Pearson D."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S.H."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Ramsey Y."/>
<person name="Rogers L."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Skuce C.D."/>
<person name="Smalley S."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Spragon L."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whiteley M.N."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Williamson H."/>
<person name="Wilmer T.E."/>
<person name="Wilming L."/>
<person name="Wright C.L."/>
<person name="Hubbard T."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Shimizu N."/>
<person name="Minoshima S."/>
<person name="Kawasaki K."/>
<person name="Sasaki T."/>
<person name="Asakawa S."/>
<person name="Kudoh J."/>
<person name="Shintani A."/>
<person name="Shibuya K."/>
<person name="Yoshizaki Y."/>
<person name="Aoki N."/>
<person name="Mitsuyama S."/>
<person name="Roe B.A."/>
<person name="Chen F."/>
<person name="Chu L."/>
<person name="Crabtree J."/>
<person name="Deschamps S."/>
<person name="Do A."/>
<person name="Do T."/>
<person name="Dorman A."/>
<person name="Fang F."/>
<person name="Fu Y."/>
<person name="Hu P."/>
<person name="Hua A."/>
<person name="Kenton S."/>
<person name="Lai H."/>
<person name="Lao H.I."/>
<person name="Lewis J."/>
<person name="Lewis S."/>
<person name="Lin S.-P."/>
<person name="Loh P."/>
<person name="Malaj E."/>
<person name="Nguyen T."/>
<person name="Pan H."/>
<person name="Phan S."/>
<person name="Qi S."/>
<person name="Qian Y."/>
<person name="Ray L."/>
<person name="Ren Q."/>
<person name="Shaull S."/>
<person name="Sloan D."/>
<person name="Song L."/>
<person name="Wang Q."/>
<person name="Wang Y."/>
<person name="Wang Z."/>
<person name="White J."/>
<person name="Willingham D."/>
<person name="Wu H."/>
<person name="Yao Z."/>
<person name="Zhan M."/>
<person name="Zhang G."/>
<person name="Chissoe S."/>
<person name="Murray J."/>
<person name="Miller N."/>
<person name="Minx P."/>
<person name="Fulton R."/>
<person name="Johnson D."/>
<person name="Bemis G."/>
<person name="Bentley D."/>
<person name="Bradshaw H."/>
<person name="Bourne S."/>
<person name="Cordes M."/>
<person name="Du Z."/>
<person name="Fulton L."/>
<person name="Goela D."/>
<person name="Graves T."/>
<person name="Hawkins J."/>
<person name="Hinds K."/>
<person name="Kemp K."/>
<person name="Latreille P."/>
<person name="Layman D."/>
<person name="Ozersky P."/>
<person name="Rohlfing T."/>
<person name="Scheet P."/>
<person name="Walker C."/>
<person name="Wamsley A."/>
<person name="Wohldmann P."/>
<person name="Pepin K."/>
<person name="Nelson J."/>
<person name="Korf I."/>
<person name="Bedell J.A."/>
<person name="Hillier L.W."/>
<person name="Mardis E."/>
<person name="Waterston R."/>
<person name="Wilson R."/>
<person name="Emanuel B.S."/>
<person name="Shaikh T."/>
<person name="Kurahashi H."/>
<person name="Saitta S."/>
<person name="Budarf M.L."/>
<person name="McDermid H.E."/>
<person name="Johnson A."/>
<person name="Wong A.C.C."/>
<person name="Morrow B.E."/>
<person name="Edelmann L."/>
<person name="Kim U.J."/>
<person name="Shizuya H."/>
<person name="Simon M.I."/>
<person name="Dumanski J.P."/>
<person name="Peyrard M."/>
<person name="Kedra D."/>
<person name="Seroussi E."/>
<person name="Fransson I."/>
<person name="Tapia I."/>
<person name="Bruder C.E."/>
<person name="O'Brien K.P."/>
<person name="Wilkinson P."/>
<person name="Bodenteich A."/>
<person name="Hartman K."/>
<person name="Hu X."/>
<person name="Khan A.S."/>
<person name="Lane L."/>
<person name="Tilahun Y."/>
<person name="Wright H."/>
</authorList>
<dbReference type="PubMed" id="10591208"/>
<dbReference type="DOI" id="10.1038/990031"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2000" name="Genes Chromosomes Cancer" volume="28" first="138" last="144">
<title>MOZ is fused to p300 in an acute monocytic leukemia with t(8;22).</title>
<authorList>
<person name="Chaffanet M."/>
<person name="Gressin L."/>
<person name="Preudhomme C."/>
<person name="Soenen-Cornu V."/>
<person name="Birnbaum D."/>
<person name="Pebusque M.-J."/>
</authorList>
<dbReference type="PubMed" id="10824998"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-2264(200006)28:2&lt;138::AID-GCC2>3.0.CO;2-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 27-42</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH KAT6A</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1995" name="Nature" volume="374" first="85" last="88">
<title>Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP.</title>
<authorList>
<person name="Lundblad J.R."/>
<person name="Kwok R.P.S."/>
<person name="Laurance M.E."/>
<person name="Harter M.L."/>
<person name="Goodman R.H."/>
</authorList>
<dbReference type="PubMed" id="7870179"/>
<dbReference type="DOI" id="10.1038/374085a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 552-660</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Science" volume="294" first="2507" last="2511">
<title>A transcriptional switch mediated by cofactor methylation.</title>
<authorList>
<person name="Xu W."/>
<person name="Chen H."/>
<person name="Du K."/>
<person name="Asahara H."/>
<person name="Tini M."/>
<person name="Emerson B.M."/>
<person name="Montminy M."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="11701890"/>
<dbReference type="DOI" id="10.1126/science.1065961"/>
</citation>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>INTERACTION WITH CARM1</scope>
<scope>METHYLATION AT ARG-580 AND ARG-604</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1996" name="Cell" volume="87" first="953" last="959">
<title>The transcriptional coactivators p300 and CBP are histone acetyltransferases.</title>
<authorList>
<person name="Ogryzko V.V."/>
<person name="Schiltz R.L."/>
<person name="Russanova V."/>
<person name="Howard B.H."/>
<person name="Nakatani Y."/>
</authorList>
<dbReference type="PubMed" id="8945521"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)82001-2"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1996" name="Nature" volume="382" first="319" last="324">
<title>A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.</title>
<authorList>
<person name="Yang X.-J."/>
<person name="Ogryzko V.V."/>
<person name="Nishikawa J."/>
<person name="Howard B.H."/>
<person name="Nakatani Y."/>
</authorList>
<dbReference type="PubMed" id="8684459"/>
<dbReference type="DOI" id="10.1038/382319a0"/>
</citation>
<scope>INTERACTION WITH PCAF</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1996" name="Proc. Natl. Acad. Sci. U.S.A." volume="93" first="12969" last="12973">
<title>An essential role for p300/CBP in the cellular response to hypoxia.</title>
<authorList>
<person name="Arany Z."/>
<person name="Huang L.E."/>
<person name="Eckner R."/>
<person name="Bhattacharya S."/>
<person name="Jiang C."/>
<person name="Goldberg M.A."/>
<person name="Bunn H.F."/>
<person name="Livingston D.M."/>
</authorList>
<dbReference type="PubMed" id="8917528"/>
<dbReference type="DOI" id="10.1073/pnas.93.23.12969"/>
</citation>
<scope>INTERACTION WITH HIF1A AND CREBBP</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="2392" last="2405">
<title>Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300.</title>
<authorList>
<person name="Bex F."/>
<person name="Yin M.-J."/>
<person name="Burny A."/>
<person name="Gaynor R.B."/>
</authorList>
<dbReference type="PubMed" id="9528808"/>
<dbReference type="DOI" id="10.1128/MCB.18.4.2392"/>
</citation>
<scope>INTERACTION WITH HTLV-1 TAX</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1998" name="Nature" volume="393" first="88" last="91">
<title>Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex.</title>
<authorList>
<person name="Fryer C.J."/>
<person name="Archer T.K."/>
</authorList>
<dbReference type="PubMed" id="9590696"/>
<dbReference type="DOI" id="10.1038/30032"/>
</citation>
<scope>INTERACTION WITH NR3C1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="6106" last="6118">
<title>HIV-1 tat transcriptional activity is regulated by acetylation.</title>
<authorList>
<person name="Kiernan R.E."/>
<person name="Vanhulle C."/>
<person name="Schiltz L."/>
<person name="Adam E."/>
<person name="Xiao H."/>
<person name="Maudoux F."/>
<person name="Calomme C."/>
<person name="Burny A."/>
<person name="Nakatani Y."/>
<person name="Jeang K.-T."/>
<person name="Benkirane M."/>
<person name="Van Lint C."/>
</authorList>
<dbReference type="PubMed" id="10545121"/>
<dbReference type="DOI" id="10.1093/emboj/18.21.6106"/>
</citation>
<scope>INTERACTION WITH HIV-1 TAT</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1999" name="Genes Dev." volume="13" first="64" last="75">
<title>Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1.</title>
<authorList>
<person name="Bhattacharya S."/>
<person name="Michels C.M."/>
<person name="Leung M.K."/>
<person name="Arany Z.P."/>
<person name="Kung A.L."/>
<person name="Livingston D.M."/>
</authorList>
<dbReference type="PubMed" id="9887100"/>
<dbReference type="DOI" id="10.1101/gad.13.1.64"/>
</citation>
<scope>INTERACTION WITH CITED2 AND HIF1A</scope>
<scope>MUTAGENESIS OF 371-THR--LEU-376 AND 413-VAL--LYS-418</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Nucleic Acids Res." volume="27" first="411" last="420">
<title>Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD.</title>
<authorList>
<person name="Lau P."/>
<person name="Bailey P."/>
<person name="Dowhan D.H."/>
<person name="Muscat G.E."/>
</authorList>
<dbReference type="PubMed" id="9862959"/>
<dbReference type="DOI" id="10.1093/nar/27.2.411"/>
</citation>
<scope>INTERACTION WITH RORA</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="8825" last="8834">
<title>The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors.</title>
<authorList>
<person name="Yahata T."/>
<person name="de Caestecker M.P."/>
<person name="Lechleider R.J."/>
<person name="Andriole S."/>
<person name="Roberts A.B."/>
<person name="Isselbacher K.J."/>
<person name="Shioda T."/>
</authorList>
<dbReference type="PubMed" id="10722728"/>
<dbReference type="DOI" id="10.1074/jbc.275.12.8825"/>
</citation>
<scope>INTERACTION WITH CITED1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="2676" last="2686">
<title>A novel transcriptional repression domain mediates p21(WAF1/CIP1) induction of p300 transactivation.</title>
<authorList>
<person name="Snowden A.W."/>
<person name="Anderson L.A."/>
<person name="Webster G.A."/>
<person name="Perkins N.D."/>
</authorList>
<dbReference type="PubMed" id="10733570"/>
<dbReference type="DOI" id="10.1128/MCB.20.8.2676-2686.2000"/>
</citation>
<scope>FUNCTION IN TRANSCRIPTIONAL REPRESSION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="5360" last="5360">
<authorList>
<person name="Snowden A.W."/>
<person name="Anderson L.A."/>
<person name="Webster G.A."/>
<person name="Perkins N.D."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="8889" last="8902">
<title>Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycle.</title>
<authorList>
<person name="Miyake S."/>
<person name="Sellers W.R."/>
<person name="Safran M."/>
<person name="Li X."/>
<person name="Zhao W."/>
<person name="Grossman S.R."/>
<person name="Gan J."/>
<person name="DeCaprio J.A."/>
<person name="Adams P.D."/>
<person name="Kaelin W.G. Jr."/>
</authorList>
<dbReference type="PubMed" id="11073989"/>
<dbReference type="DOI" id="10.1128/MCB.20.23.8889-8902.2000"/>
</citation>
<scope>INTERACTION WITH EID1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="8903" last="8915">
<title>A novel Rb- and p300-binding protein inhibits transactivation by MyoD.</title>
<authorList>
<person name="MacLellan W.R."/>
<person name="Xiao G."/>
<person name="Abdellatif M."/>
<person name="Schneider M.D."/>
</authorList>
<dbReference type="PubMed" id="11073990"/>
<dbReference type="DOI" id="10.1128/MCB.20.23.8903-8915.2000"/>
</citation>
<scope>INTERACTION WITH EID1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="6212" last="6217">
<title>Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator.</title>
<authorList>
<person name="Ko L."/>
<person name="Cardona G.R."/>
<person name="Chin W.W."/>
</authorList>
<dbReference type="PubMed" id="10823961"/>
<dbReference type="DOI" id="10.1073/pnas.97.11.6212"/>
</citation>
<scope>INTERACTION WITH NCOA6</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2000" name="Virology" volume="277" first="278" last="295">
<title>Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.</title>
<authorList>
<person name="Deng L."/>
<person name="de la Fuente C."/>
<person name="Fu P."/>
<person name="Wang L."/>
<person name="Donnelly R."/>
<person name="Wade J.D."/>
<person name="Lambert P."/>
<person name="Li H."/>
<person name="Lee C.-G."/>
<person name="Kashanchi F."/>
</authorList>
<dbReference type="PubMed" id="11080476"/>
<dbReference type="DOI" id="10.1006/viro.2000.0593"/>
</citation>
<scope>INTERACTION WITH HIV-1 TAT</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2001" name="Genes Dev." volume="15" first="2598" last="2612">
<title>Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein.</title>
<authorList>
<person name="Yahata T."/>
<person name="Shao W."/>
<person name="Endoh H."/>
<person name="Hur J."/>
<person name="Coser K.R."/>
<person name="Sun H."/>
<person name="Ueda Y."/>
<person name="Kato S."/>
<person name="Isselbacher K.J."/>
<person name="Brown M."/>
<person name="Shioda T."/>
</authorList>
<dbReference type="PubMed" id="11581164"/>
<dbReference type="DOI" id="10.1101/gad.906301"/>
</citation>
<scope>INTERACTION WITH ESR1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="38341" last="38344">
<title>Regulation of transcription by AMP-activated protein kinase: phosphorylation of p300 blocks its interaction with nuclear receptors.</title>
<authorList>
<person name="Yang W."/>
<person name="Hong Y.H."/>
<person name="Shen X.Q."/>
<person name="Frankowski C."/>
<person name="Camp H.S."/>
<person name="Leff T."/>
</authorList>
<dbReference type="PubMed" id="11518699"/>
<dbReference type="DOI" id="10.1074/jbc.C100316200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-89</scope>
<scope>MUTAGENESIS OF SER-89</scope>
<scope>INTERACTION WITH PPARG</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2001" name="J. Virol." volume="75" first="10033" last="10040">
<title>Adenovirus DNA binding protein interacts with the SNF2-related CBP activator protein (SrCap) and inhibits SrCap-mediated transcription.</title>
<authorList>
<person name="Xu X."/>
<person name="Chackalaparampil I."/>
<person name="Monroy M.A."/>
<person name="Cannella M.T."/>
<person name="Pesek E."/>
<person name="Chrivia J."/>
<person name="Yaciuk P."/>
</authorList>
<dbReference type="PubMed" id="11581372"/>
<dbReference type="DOI" id="10.1128/JVI.75.21.10033-10040.2001"/>
</citation>
<scope>INTERACTION WITH SRCAP</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="5520" last="5530">
<title>The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation.</title>
<authorList>
<person name="Scoggin K.E.S."/>
<person name="Ulloa A."/>
<person name="Nyborg J.K."/>
</authorList>
<dbReference type="PubMed" id="11463834"/>
<dbReference type="DOI" id="10.1128/MCB.21.16.5520-5530.2001"/>
</citation>
<scope>INTERACTION WITH HTLV-1 TAX</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2001" name="J. Virol." volume="75" first="9885" last="9895">
<title>Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.</title>
<authorList>
<person name="Zhang W."/>
<person name="Nisbet J.W."/>
<person name="Albrecht B."/>
<person name="Ding W."/>
<person name="Kashanchi F."/>
<person name="Bartoe J.T."/>
<person name="Lairmore M.D."/>
</authorList>
<dbReference type="PubMed" id="11559821"/>
<dbReference type="DOI" id="10.1128/JVI.75.20.9885-9895.2001"/>
</citation>
<scope>INTERACTION WITH HTLV-1 ACCESSORY PROTEIN P30II</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="33881" last="33892">
<title>A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression.</title>
<authorList>
<person name="Gizard F."/>
<person name="Lavallee B."/>
<person name="DeWitte F."/>
<person name="Hum D.W."/>
</authorList>
<dbReference type="PubMed" id="11349124"/>
<dbReference type="DOI" id="10.1074/jbc.M100113200"/>
</citation>
<scope>INTERACTION WITH TRERF1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="38272" last="38279">
<title>Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.</title>
<authorList>
<person name="Vadlamudi R.K."/>
<person name="Wang R.-A."/>
<person name="Mazumdar A."/>
<person name="Kim Y.-S."/>
<person name="Shin J."/>
<person name="Sahin A."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="11481323"/>
<dbReference type="DOI" id="10.1074/jbc.M103783200"/>
</citation>
<scope>INTERACTION WITH PELP1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="45031" last="45040">
<title>Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor.</title>
<authorList>
<person name="Yamamoto N."/>
<person name="Yamamoto S."/>
<person name="Inagaki F."/>
<person name="Kawaichi M."/>
<person name="Fukamizu A."/>
<person name="Kishi N."/>
<person name="Matsuno K."/>
<person name="Nakamura K."/>
<person name="Weinmaster G."/>
<person name="Okano H."/>
<person name="Nakafuku M."/>
</authorList>
<dbReference type="PubMed" id="11564735"/>
<dbReference type="DOI" id="10.1074/jbc.M105245200"/>
</citation>
<scope>INTERACTION WITH DTX1</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2001" name="Mol. Cell" volume="7" first="1221" last="1231">
<title>Regulation of human flap endonuclease-1 activity by acetylation through the transcriptional coactivator p300.</title>
<authorList>
<person name="Hasan S."/>
<person name="Stucki M."/>
<person name="Hassa P.O."/>
<person name="Imhof R."/>
<person name="Gehrig P."/>
<person name="Hunziker P."/>
<person name="Hubscher U."/>
<person name="Hottiger M.O."/>
</authorList>
<dbReference type="PubMed" id="11430825"/>
<dbReference type="DOI" id="10.1016/S1097-2765(01)00272-6"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FEN1</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2001" name="Nat. Cell Biol." volume="3" first="667" last="674">
<title>Acetylation control of the retinoblastoma tumour-suppressor protein.</title>
<authorList>
<person name="Chan H.M."/>
<person name="Krstic-Demonacos M."/>
<person name="Smith L."/>
<person name="Demonacos C."/>
<person name="La Thangue N.B."/>
</authorList>
<dbReference type="PubMed" id="11433299"/>
<dbReference type="DOI" id="10.1038/35083062"/>
</citation>
<scope>INTERACTION WITH HADV5 E1A</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2002" name="Cell Growth Differ." volume="13" first="69" last="75">
<title>Interaction between the hematopoietic Ets transcription factor Spi-B and the coactivator CREB-binding protein associated with negative cross-talk with c-Myb.</title>
<authorList>
<person name="Yamamoto H."/>
<person name="Kihara-Negishi F."/>
<person name="Yamada T."/>
<person name="Suzuki M."/>
<person name="Nakano T."/>
<person name="Oikawa T."/>
</authorList>
<dbReference type="PubMed" id="11864910"/>
</citation>
<scope>INTERACTION WITH SPIB</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="8559" last="8565">
<title>Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2.</title>
<authorList>
<person name="Braganca J."/>
<person name="Swingler T."/>
<person name="Marques F.I.R."/>
<person name="Jones T."/>
<person name="Eloranta J.J."/>
<person name="Hurst H.C."/>
<person name="Shioda T."/>
<person name="Bhattacharya S."/>
</authorList>
<dbReference type="PubMed" id="11744733"/>
<dbReference type="DOI" id="10.1074/jbc.M110850200"/>
</citation>
<scope>INTERACTION WITH CITED4</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="2598" last="2606">
<title>Scaffold/matrix attachment region elements interact with a p300-scaffold attachment factor A complex and are bound by acetylated nucleosomes.</title>
<authorList>
<person name="Martens J.H."/>
<person name="Verlaan M."/>
<person name="Kalkhoven E."/>
<person name="Dorsman J.C."/>
<person name="Zantema A."/>
</authorList>
<dbReference type="PubMed" id="11909954"/>
</citation>
<scope>INTERACTION WITH HNRNPU</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="3621" last="3632">
<title>Synergy among nuclear receptor coactivators: selective requirement for protein methyltransferase and acetyltransferase activities.</title>
<authorList>
<person name="Lee Y.-H."/>
<person name="Koh S.S."/>
<person name="Zhang X."/>
<person name="Cheng X."/>
<person name="Stallcup M.R."/>
</authorList>
<dbReference type="PubMed" id="11997499"/>
<dbReference type="DOI" id="10.1128/MCB.22.11.3621-3632.2002"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH CARM1 AND NCOA2</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2002" name="Nat. Genet." volume="32" first="606" last="613">
<title>Acetylation inactivates the transcriptional repressor BCL6.</title>
<authorList>
<person name="Bereshchenko O.R."/>
<person name="Gu W."/>
<person name="Dalla-Favera R."/>
</authorList>
<dbReference type="PubMed" id="12402037"/>
<dbReference type="DOI" id="10.1038/ng1018"/>
</citation>
<scope>FUNCTION IN BCL6 ACETYLATION</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="2373" last="2378">
<title>p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.</title>
<authorList>
<person name="Shiseki M."/>
<person name="Nagashima M."/>
<person name="Pedeux R.M."/>
<person name="Kitahama-Shiseki M."/>
<person name="Miura K."/>
<person name="Okamura S."/>
<person name="Onogi H."/>
<person name="Higashimoto Y."/>
<person name="Appella E."/>
<person name="Yokota J."/>
<person name="Harris C.C."/>
</authorList>
<dbReference type="PubMed" id="12750254"/>
</citation>
<scope>INTERACTION WITH ING4 AND ING5</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="3776" last="3785">
<title>Identification of a promoter-specific transcriptional activation domain at the C-terminus of the Wnt effector protein T-cell factor 4.</title>
<authorList>
<person name="Hecht A."/>
<person name="Stemmler M.P."/>
</authorList>
<dbReference type="PubMed" id="12446687"/>
<dbReference type="DOI" id="10.1074/jbc.M210081200"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH TCF7L2 AND LEF1</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="16021" last="16029">
<title>Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2.</title>
<authorList>
<person name="Braganca J."/>
<person name="Eloranta J.J."/>
<person name="Bamforth S.D."/>
<person name="Ibbitt J.C."/>
<person name="Hurst H.C."/>
<person name="Bhattacharya S."/>
</authorList>
<dbReference type="PubMed" id="12586840"/>
<dbReference type="DOI" id="10.1074/jbc.M208144200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CITED2 AND TFAP2A</scope>
<scope>MUTAGENESIS OF ASP-1399</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="35775" last="35780">
<title>Acetylated SP3 is a transcriptional activator.</title>
<authorList>
<person name="Ammanamanchi S."/>
<person name="Freeman J.W."/>
<person name="Brattain M.G."/>
</authorList>
<dbReference type="PubMed" id="12837748"/>
<dbReference type="DOI" id="10.1074/jbc.M305961200"/>
</citation>
<scope>INTERACTION WITH SP3</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2003" name="J. Bone Miner. Res." volume="18" first="1419" last="1429">
<title>P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.</title>
<authorList>
<person name="Iioka T."/>
<person name="Furukawa K."/>
<person name="Yamaguchi A."/>
<person name="Shindo H."/>
<person name="Yamashita S."/>
<person name="Tsukazaki T."/>
</authorList>
<dbReference type="PubMed" id="12929931"/>
<dbReference type="DOI" id="10.1359/jbmr.2003.18.8.1419"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ALX1</scope>
<scope>REGION</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2003" name="Microbiol. Immunol." volume="47" first="803" last="811">
<title>SATB1 makes a complex with p300 and represses gp91(phox) promoter activity.</title>
<authorList>
<person name="Fujii Y."/>
<person name="Kumatori A."/>
<person name="Nakamura M."/>
</authorList>
<dbReference type="PubMed" id="14605447"/>
<dbReference type="DOI" id="10.1111/j.1348-0421.2003.tb03438.x"/>
</citation>
<scope>INTERACTION WITH SATB1</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2003" name="Mol. Cell" volume="11" first="1043" last="1054">
<title>P300 transcriptional repression is mediated by SUMO modification.</title>
<authorList>
<person name="Girdwood D."/>
<person name="Bumpass D."/>
<person name="Vaughan O.A."/>
<person name="Thain A."/>
<person name="Anderson L.A."/>
<person name="Snowden A.W."/>
<person name="Garcia-Wilson E."/>
<person name="Perkins N.D."/>
<person name="Hay R.T."/>
</authorList>
<dbReference type="PubMed" id="12718889"/>
<dbReference type="DOI" id="10.1016/S1097-2765(03)00141-2"/>
</citation>
<scope>SUMOYLATION AT LYS-1020 AND LYS-1024</scope>
<scope>MUTAGENESIS OF LYS-1020 AND LYS-1024</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="151" last="156">
<title>Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300.</title>
<authorList>
<person name="Rossow K.L."/>
<person name="Janknecht R."/>
</authorList>
<dbReference type="PubMed" id="12527917"/>
<dbReference type="DOI" id="10.1038/sj.onc.1206067"/>
</citation>
<scope>INTERACTION WITH DDX5</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2004" name="Cell" volume="117" first="735" last="748">
<title>Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53.</title>
<authorList>
<person name="An W."/>
<person name="Kim J."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="15186775"/>
<dbReference type="DOI" id="10.1016/j.cell.2004.05.009"/>
</citation>
<scope>INTERACTION WITH TP53</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="3336" last="3345">
<title>Regulation of human SRY subcellular distribution by its acetylation/deacetylation.</title>
<authorList>
<person name="Thevenet L."/>
<person name="Mejean C."/>
<person name="Moniot B."/>
<person name="Bonneaud N."/>
<person name="Galeotti N."/>
<person name="Aldrian-Herrada G."/>
<person name="Poulat F."/>
<person name="Berta P."/>
<person name="Benkirane M."/>
<person name="Boizet-Bonhoure B."/>
</authorList>
<dbReference type="PubMed" id="15297880"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600352"/>
</citation>
<scope>INTERACTION WITH SRY</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="7091" last="7097">
<title>Histone acetyltransferase-dependent chromatin remodeling and the vascular clock.</title>
<authorList>
<person name="Curtis A.M."/>
<person name="Seo S.B."/>
<person name="Westgate E.J."/>
<person name="Rudic R.D."/>
<person name="Smyth E.M."/>
<person name="Chakravarti D."/>
<person name="FitzGerald G.A."/>
<person name="McNamara P."/>
</authorList>
<dbReference type="PubMed" id="14645221"/>
<dbReference type="DOI" id="10.1074/jbc.M311973200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH NPAS2; ARNTL/BMAL1 AND CLOCK</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="25241" last="25250">
<title>Positive and negative modulation of the transcriptional activity of the ETS factor ESE-1 through interaction with p300, CREB-binding protein, and Ku 70/86.</title>
<authorList>
<person name="Wang H."/>
<person name="Fang R."/>
<person name="Cho J.-Y."/>
<person name="Libermann T.A."/>
<person name="Oettgen P."/>
</authorList>
<dbReference type="PubMed" id="15075319"/>
<dbReference type="DOI" id="10.1074/jbc.M401356200"/>
</citation>
<scope>INTERACTION WITH ELF3</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="10083" last="10098">
<title>Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53.</title>
<authorList>
<person name="Dornan D."/>
<person name="Eckert M."/>
<person name="Wallace M."/>
<person name="Shimizu H."/>
<person name="Ramsay E."/>
<person name="Hupp T.R."/>
<person name="Ball K.L."/>
</authorList>
<dbReference type="PubMed" id="15509808"/>
<dbReference type="DOI" id="10.1128/MCB.24.22.10083-10098.2004"/>
</citation>
<scope>INTERACTION WITH IRF1</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2004" name="Nat. Struct. Mol. Biol." volume="11" first="308" last="315">
<title>Regulation of the p300 HAT domain via a novel activation loop.</title>
<authorList>
<person name="Thompson P.R."/>
<person name="Wang D."/>
<person name="Wang L."/>
<person name="Fulco M."/>
<person name="Pediconi N."/>
<person name="Zhang D."/>
<person name="An W."/>
<person name="Ge Q."/>
<person name="Roeder R.G."/>
<person name="Wong J."/>
<person name="Levrero M."/>
<person name="Sartorelli V."/>
<person name="Cotter R.J."/>
<person name="Cole P.A."/>
</authorList>
<dbReference type="PubMed" id="15004546"/>
<dbReference type="DOI" id="10.1038/nsmb740"/>
</citation>
<scope>ACETYLATION AT LYS-1499; LYS-1549; LYS-1554; LYS-1558 AND LYS-1560</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2004" name="Mol. Endocrinol." volume="18" first="776" last="790">
<title>Orphan nuclear receptor small heterodimer partner, a novel corepressor for a basic helix-loop-helix transcription factor BETA2/neuroD.</title>
<authorList>
<person name="Kim J.Y."/>
<person name="Chu K."/>
<person name="Kim H.J."/>
<person name="Seong H.A."/>
<person name="Park K.C."/>
<person name="Sanyal S."/>
<person name="Takeda J."/>
<person name="Ha H."/>
<person name="Shong M."/>
<person name="Tsai M.J."/>
<person name="Choi H.S."/>
</authorList>
<dbReference type="PubMed" id="14752053"/>
<dbReference type="DOI" id="10.1210/me.2003-0311"/>
</citation>
<scope>INTERACTION WITH NEUROD1 AND TCF3</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2004" name="Science" volume="303" first="197" last="202">
<title>Dendrite development regulated by CREST, a calcium-regulated transcriptional activator.</title>
<authorList>
<person name="Aizawa H."/>
<person name="Hu S.-C."/>
<person name="Bobb K."/>
<person name="Balakrishnan K."/>
<person name="Ince G."/>
<person name="Gurevich I."/>
<person name="Cowan M."/>
<person name="Ghosh A."/>
</authorList>
<dbReference type="PubMed" id="14716005"/>
<dbReference type="DOI" id="10.1126/science.1089845"/>
</citation>
<scope>INTERACTION WITH SS18L1/CREST</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2005" name="Am. J. Hum. Genet." volume="76" first="572" last="580">
<title>Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease.</title>
<authorList>
<person name="Roelfsema J.H."/>
<person name="White S.J."/>
<person name="Ariyuerek Y."/>
<person name="Bartholdi D."/>
<person name="Niedrist D."/>
<person name="Papadia F."/>
<person name="Bacino C.A."/>
<person name="den Dunnen J.T."/>
<person name="van Ommen G.-J.B."/>
<person name="Breuning M.H."/>
<person name="Hennekam R.C."/>
<person name="Peters D.J.M."/>
</authorList>
<dbReference type="PubMed" id="15706485"/>
<dbReference type="DOI" id="10.1086/429130"/>
</citation>
<scope>INVOLVEMENT IN RSTS2</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="10264" last="10276">
<title>SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1.</title>
<authorList>
<person name="Bouras T."/>
<person name="Fu M."/>
<person name="Sauve A.A."/>
<person name="Wang F."/>
<person name="Quong A.A."/>
<person name="Perkins N.D."/>
<person name="Hay R.T."/>
<person name="Gu W."/>
<person name="Pestell R.G."/>
</authorList>
<dbReference type="PubMed" id="15632193"/>
<dbReference type="DOI" id="10.1074/jbc.M408748200"/>
</citation>
<scope>DEACETYLATION BY SIRT1</scope>
<scope>ACETYLATION AT LYS-1020 AND LYS-1024</scope>
<scope>MUTAGENESIS OF LYS-1020 AND LYS-1024</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2005" name="Mol. Endocrinol." volume="19" first="2283" last="2298">
<title>The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription.</title>
<authorList>
<person name="Perrot V."/>
<person name="Rechler M.M."/>
</authorList>
<dbReference type="PubMed" id="15890677"/>
<dbReference type="DOI" id="10.1210/me.2004-0292"/>
</citation>
<scope>INTERACTION WITH FOXO1</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ASP-1399</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="3611" last="3616">
<title>Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination.</title>
<authorList>
<person name="Lee Y.-H."/>
<person name="Coonrod S.A."/>
<person name="Kraus W.L."/>
<person name="Jelinek M.A."/>
<person name="Stallcup M.R."/>
</authorList>
<dbReference type="PubMed" id="15731352"/>
<dbReference type="DOI" id="10.1073/pnas.0407159102"/>
</citation>
<scope>METHYLATION AT ARG-2142</scope>
<scope>CITRULLINATION AT ARG-2142</scope>
<scope>INTERACTION WITH NCOA2</scope>
<scope>MUTAGENESIS OF ARG-2056; ARG-2088 AND ARG-2142</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2006" name="Blood" volume="108" first="2695" last="2702">
<title>BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes.</title>
<authorList>
<person name="Cismasiu V.B."/>
<person name="Ghanta S."/>
<person name="Duque J."/>
<person name="Albu D.I."/>
<person name="Chen H.M."/>
<person name="Kasturi R."/>
<person name="Avram D."/>
</authorList>
<dbReference type="PubMed" id="16809611"/>
<dbReference type="DOI" id="10.1182/blood-2006-05-021790"/>
</citation>
<scope>INTERACTION WITH BCL11B</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="15320" last="15329">
<title>Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase.</title>
<authorList>
<person name="Tanaka T."/>
<person name="Nishimura D."/>
<person name="Wu R.C."/>
<person name="Amano M."/>
<person name="Iso T."/>
<person name="Kedes L."/>
<person name="Nishida H."/>
<person name="Kaibuchi K."/>
<person name="Hamamori Y."/>
</authorList>
<dbReference type="PubMed" id="16574662"/>
<dbReference type="DOI" id="10.1074/jbc.M510954200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ROCK2</scope>
<scope>PHOSPHORYLATION AT SER-89</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="27426" last="27435">
<title>The transcriptional activity of CITED1 is regulated by phosphorylation in a cell cycle-dependent manner.</title>
<authorList>
<person name="Shi G."/>
<person name="Boyle S.C."/>
<person name="Sparrow D.B."/>
<person name="Dunwoodie S.L."/>
<person name="Shioda T."/>
<person name="de Caestecker M.P."/>
</authorList>
<dbReference type="PubMed" id="16864582"/>
<dbReference type="DOI" id="10.1074/jbc.M602631200"/>
</citation>
<scope>INTERACTION WITH CITED1</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="40292" last="40301">
<title>Kinetic and mass spectrometric analysis of p300 histone acetyltransferase domain autoacetylation.</title>
<authorList>
<person name="Karanam B."/>
<person name="Jiang L."/>
<person name="Wang L."/>
<person name="Kelleher N.L."/>
<person name="Cole P.A."/>
</authorList>
<dbReference type="PubMed" id="17065153"/>
<dbReference type="DOI" id="10.1074/jbc.M608813200"/>
</citation>
<scope>ACETYLATION AT LYS-1336 AND LYS-1473</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2006" name="Mol. Cell" volume="22" first="669" last="679">
<title>HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription.</title>
<authorList>
<person name="Qiu Y."/>
<person name="Zhao Y."/>
<person name="Becker M."/>
<person name="John S."/>
<person name="Parekh B.S."/>
<person name="Huang S."/>
<person name="Hendarwanto A."/>
<person name="Martinez E.D."/>
<person name="Chen Y."/>
<person name="Lu H."/>
<person name="Adkins N.L."/>
<person name="Stavreva D.A."/>
<person name="Wiench M."/>
<person name="Georgel P.T."/>
<person name="Schiltz R.L."/>
<person name="Hager G.L."/>
</authorList>
<dbReference type="PubMed" id="16762839"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.04.019"/>
</citation>
<scope>FUNCTION IN ACETYLATION OF HDAC1</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="1770" last="1785">
<title>Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12(S)-lipoxygenase gene transcription.</title>
<authorList>
<person name="Hung J.J."/>
<person name="Wang Y.T."/>
<person name="Chang W.C."/>
</authorList>
<dbReference type="PubMed" id="16478997"/>
<dbReference type="DOI" id="10.1128/MCB.26.5.1770-1785.2006"/>
</citation>
<scope>INTERACTION WITH SP1</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="6670" last="6675">
<title>MTA1, a transcriptional activator of breast cancer amplified sequence 3.</title>
<authorList>
<person name="Gururaj A.E."/>
<person name="Singh R.R."/>
<person name="Rayala S.K."/>
<person name="Holm C."/>
<person name="den Hollander P."/>
<person name="Zhang H."/>
<person name="Balasenthil S."/>
<person name="Talukder A.H."/>
<person name="Landberg G."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="16617102"/>
<dbReference type="DOI" id="10.1073/pnas.0601989103"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MTA1</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="4147" last="4148">
<authorList>
<person name="Gururaj A.E."/>
<person name="Singh R.R."/>
<person name="Rayala S.K."/>
<person name="Holm C."/>
<person name="den Hollander P."/>
<person name="Zhang H."/>
<person name="Balasenthil S."/>
<person name="Talukder A.H."/>
<person name="Landberg G."/>
<person name="Kumar R."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="35687" last="35694">
<title>Critical and functional regulation of CHOP (C/EBP homologous protein) through the N-terminal portion.</title>
<authorList>
<person name="Ohoka N."/>
<person name="Hattori T."/>
<person name="Kitagawa M."/>
<person name="Onozaki K."/>
<person name="Hayashi H."/>
</authorList>
<dbReference type="PubMed" id="17872950"/>
<dbReference type="DOI" id="10.1074/jbc.M703735200"/>
</citation>
<scope>INTERACTION WITH DDIT3</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2007" name="J. Cell. Biochem." volume="101" first="1252" last="1265">
<title>Concerted activation of the Mdm2 promoter by p72 RNA helicase and the coactivators p300 and P/CAF.</title>
<authorList>
<person name="Shin S."/>
<person name="Janknecht R."/>
</authorList>
<dbReference type="PubMed" id="17226766"/>
<dbReference type="DOI" id="10.1002/jcb.21250"/>
</citation>
<scope>INTERACTION WITH DDX17</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2007" name="Mol. Cell. Proteomics" volume="6" first="812" last="819">
<title>Lysine propionylation and butyrylation are novel post-translational modifications in histones.</title>
<authorList>
<person name="Chen Y."/>
<person name="Sprung R."/>
<person name="Tang Y."/>
<person name="Ball H."/>
<person name="Sangras B."/>
<person name="Kim S.C."/>
<person name="Falck J.R."/>
<person name="Peng J."/>
<person name="Gu W."/>
<person name="Zhao Y."/>
</authorList>
<dbReference type="PubMed" id="17267393"/>
<dbReference type="DOI" id="10.1074/mcp.M700021-MCP200"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="375" first="576" last="580">
<title>Acetylation of Sirt2 by p300 attenuates its deacetylase activity.</title>
<authorList>
<person name="Han Y."/>
<person name="Jin Y.H."/>
<person name="Kim Y.J."/>
<person name="Kang B.Y."/>
<person name="Choi H.J."/>
<person name="Kim D.W."/>
<person name="Yeo C.Y."/>
<person name="Lee K.Y."/>
</authorList>
<dbReference type="PubMed" id="18722353"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2008.08.042"/>
</citation>
<scope>FUNCTION IN ACETYLATION OF SIRT2</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2008" name="Blood" volume="112" first="3777" last="3787">
<title>PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.</title>
<authorList>
<person name="Wee H.-J."/>
<person name="Voon D.C.-C."/>
<person name="Bae S.-C."/>
<person name="Ito Y."/>
</authorList>
<dbReference type="PubMed" id="18695000"/>
<dbReference type="DOI" id="10.1182/blood-2008-01-134122"/>
</citation>
<scope>PHOSPHORYLATION BY HIPK2</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="7126" last="7138">
<title>PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation.</title>
<authorList>
<person name="Shima Y."/>
<person name="Shima T."/>
<person name="Chiba T."/>
<person name="Irimura T."/>
<person name="Pandolfi P.P."/>
<person name="Kitabayashi I."/>
</authorList>
<dbReference type="PubMed" id="18809579"/>
<dbReference type="DOI" id="10.1128/MCB.00897-08"/>
</citation>
<scope>FBXO3-MEDIATED DEGRADATION</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2008" name="Mol. Cell" volume="32" first="449" last="455">
<title>The SIRT2 deacetylase regulates autoacetylation of p300.</title>
<authorList>
<person name="Black J.C."/>
<person name="Mosley A."/>
<person name="Kitada T."/>
<person name="Washburn M."/>
<person name="Carey M."/>
</authorList>
<dbReference type="PubMed" id="18995842"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.09.018"/>
</citation>
<scope>ACETYLATION AT LYS-418; LYS-423; LYS-1542; LYS-1546; LYS-1549; LYS-1699; LYS-1704 AND LYS-1707</scope>
<scope>DEACETYLATION BY SIRT2</scope>
<scope>FUNCTION IN TRANSCRIPTIONAL REGULATION</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="73">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2009" name="EMBO J." volume="28" first="2748" last="2762">
<title>SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation.</title>
<authorList>
<person name="Huang C."/>
<person name="Han Y."/>
<person name="Wang Y."/>
<person name="Sun X."/>
<person name="Yan S."/>
<person name="Yeh E.T.H."/>
<person name="Chen Y."/>
<person name="Cang H."/>
<person name="Li H."/>
<person name="Shi G."/>
<person name="Cheng J."/>
<person name="Tang X."/>
<person name="Yi J."/>
</authorList>
<dbReference type="PubMed" id="19680224"/>
<dbReference type="DOI" id="10.1038/emboj.2009.210"/>
</citation>
<scope>INTERACTION WITH SENP3</scope>
<scope>SUMOYLATION</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="76">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-636; LYS-977; LYS-1542; LYS-1546; LYS-1554; LYS-1555; LYS-1558; LYS-1560 AND LYS-1583</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="9556" last="9568">
<title>Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes.</title>
<authorList>
<person name="Sunagawa Y."/>
<person name="Morimoto T."/>
<person name="Takaya T."/>
<person name="Kaichi S."/>
<person name="Wada H."/>
<person name="Kawamura T."/>
<person name="Fujita M."/>
<person name="Shimatsu A."/>
<person name="Kita T."/>
<person name="Hasegawa K."/>
</authorList>
<dbReference type="PubMed" id="20081228"/>
<dbReference type="DOI" id="10.1074/jbc.M109.070458"/>
</citation>
<scope>IDENTIFICATION IN COMPLEX WITH CCNT1; CDK9 AND GATA4</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="40830" last="40837">
<title>HDAC3 is negatively regulated by the nuclear protein DBC1.</title>
<authorList>
<person name="Chini C.C."/>
<person name="Escande C."/>
<person name="Nin V."/>
<person name="Chini E.N."/>
</authorList>
<dbReference type="PubMed" id="21030595"/>
<dbReference type="DOI" id="10.1074/jbc.M110.153270"/>
</citation>
<scope>FUNCTION IN ACETYLATION OF MEF2D</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2011" name="Biochem. J." volume="433" first="245" last="252">
<title>Regulation of unfolded protein response modulator XBP1s by acetylation and deacetylation.</title>
<authorList>
<person name="Wang F.M."/>
<person name="Chen Y.J."/>
<person name="Ouyang H.J."/>
</authorList>
<dbReference type="PubMed" id="20955178"/>
<dbReference type="DOI" id="10.1042/BJ20101293"/>
</citation>
<scope>FUNCTION IN ACETYLATION OF XBP1</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1038</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="82">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.M111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="83">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E49045" last="E49045">
<title>Human ALKBH4 interacts with proteins associated with transcription.</title>
<authorList>
<person name="Bjornstad L.G."/>
<person name="Meza T.J."/>
<person name="Otterlei M."/>
<person name="Olafsrud S.M."/>
<person name="Meza-Zepeda L.A."/>
<person name="Falnes P.O."/>
</authorList>
<dbReference type="PubMed" id="23145062"/>
<dbReference type="DOI" id="10.1371/journal.pone.0049045"/>
</citation>
<scope>INTERACTION WITH ALKBH4</scope>
</reference>
<reference key="84">
<citation type="journal article" date="2013" name="Cell" volume="152" first="859" last="872">
<title>Regulation of transcription through acetylation of H3K122 on the lateral surface of the histone octamer.</title>
<authorList>
<person name="Tropberger P."/>
<person name="Pott S."/>
<person name="Keller C."/>
<person name="Kamieniarz-Gdula K."/>
<person name="Caron M."/>
<person name="Richter F."/>
<person name="Li G."/>
<person name="Mittler G."/>
<person name="Liu E.T."/>
<person name="Buhler M."/>
<person name="Margueron R."/>
<person name="Schneider R."/>
</authorList>
<dbReference type="PubMed" id="23415232"/>
<dbReference type="DOI" id="10.1016/j.cell.2013.01.032"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="85">
<citation type="journal article" date="2013" name="Cell Rep." volume="4" first="578" last="588">
<title>A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters.</title>
<authorList>
<person name="Hatzi K."/>
<person name="Jiang Y."/>
<person name="Huang C."/>
<person name="Garrett-Bakelman F."/>
<person name="Gearhart M.D."/>
<person name="Giannopoulou E.G."/>
<person name="Zumbo P."/>
<person name="Kirouac K."/>
<person name="Bhaskara S."/>
<person name="Polo J.M."/>
<person name="Kormaksson M."/>
<person name="Mackerell A.D. Jr."/>
<person name="Xue F."/>
<person name="Mason C.E."/>
<person name="Hiebert S.W."/>
<person name="Prive G.G."/>
<person name="Cerchietti L."/>
<person name="Bardwell V.J."/>
<person name="Elemento O."/>
<person name="Melnick A."/>
</authorList>
<dbReference type="PubMed" id="23911289"/>
<dbReference type="DOI" id="10.1016/j.celrep.2013.06.016"/>
</citation>
<scope>FUNCTION AS ACETYLTRANSFERASE OF H3K27</scope>
</reference>
<reference key="86">
<citation type="journal article" date="2013" name="J. Clin. Invest." volume="123" first="4232" last="4241">
<title>Kruppel-like factor 15 is critical for vascular inflammation.</title>
<authorList>
<person name="Lu Y."/>
<person name="Zhang L."/>
<person name="Liao X."/>
<person name="Sangwung P."/>
<person name="Prosdocimo D.A."/>
<person name="Zhou G."/>
<person name="Votruba A.R."/>
<person name="Brian L."/>
<person name="Han Y.J."/>
<person name="Gao H."/>
<person name="Wang Y."/>
<person name="Shimizu K."/>
<person name="Weinert-Stein K."/>
<person name="Khrestian M."/>
<person name="Simon D.I."/>
<person name="Freedman N.J."/>
<person name="Jain M.K."/>
</authorList>
<dbReference type="PubMed" id="23999430"/>
<dbReference type="DOI" id="10.1172/JCI68552"/>
</citation>
<scope>INTERACTION WITH KLF15</scope>
</reference>
<reference key="87">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1038 AND SER-1726</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="88">
<citation type="journal article" date="2014" name="Cancer Res." volume="74" first="1484" last="1494">
<title>Differential regulation of estrogen receptor alpha expression in breast cancer cells by metastasis-associated protein 1.</title>
<authorList>
<person name="Kang H.J."/>
<person name="Lee M.H."/>
<person name="Kang H.L."/>
<person name="Kim S.H."/>
<person name="Ahn J.R."/>
<person name="Na H."/>
<person name="Na T.Y."/>
<person name="Kim Y.N."/>
<person name="Seong J.K."/>
<person name="Lee M.O."/>
</authorList>
<dbReference type="PubMed" id="24413532"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-13-2020"/>
</citation>
<scope>INTERACTION WITH HDAC4 AND HDAC5</scope>
</reference>
<reference key="89">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="2072" last="2083">
<title>Zinc finger protein 451 is a novel Smad corepressor in transforming growth factor-beta signaling.</title>
<authorList>
<person name="Feng Y."/>
<person name="Wu H."/>
<person name="Xu Y."/>
<person name="Zhang Z."/>
<person name="Liu T."/>
<person name="Lin X."/>
<person name="Feng X.H."/>
</authorList>
<dbReference type="PubMed" id="24324267"/>
<dbReference type="DOI" id="10.1074/jbc.M113.526905"/>
</citation>
<scope>INTERACTION WITH ZNF451</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="90">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="4018" last="4031">
<title>Human Kruppel-related 3 (HKR3) is a novel transcription activator of alternate reading frame (ARF) gene.</title>
<authorList>
<person name="Yoon J.H."/>
<person name="Choi W.I."/>
<person name="Jeon B.N."/>
<person name="Koh D.I."/>
<person name="Kim M.K."/>
<person name="Kim M.H."/>
<person name="Kim J."/>
<person name="Hur S.S."/>
<person name="Kim K.S."/>
<person name="Hur M.W."/>
</authorList>
<dbReference type="PubMed" id="24382891"/>
<dbReference type="DOI" id="10.1074/jbc.M113.526855"/>
</citation>
<scope>INTERACTION WITH ZBTB48</scope>
</reference>
<reference key="91">
<citation type="journal article" date="2014" name="J. Mol. Biol." volume="426" first="1677" last="1691">
<title>Constitutive nuclear localization of an alternatively spliced sirtuin-2 isoform.</title>
<authorList>
<person name="Rack J.G."/>
<person name="Vanlinden M.R."/>
<person name="Lutter T."/>
<person name="Aasland R."/>
<person name="Ziegler M."/>
</authorList>
<dbReference type="PubMed" id="24177535"/>
<dbReference type="DOI" id="10.1016/j.jmb.2013.10.027"/>
</citation>
<scope>ACETYLATION</scope>
<scope>DEACETYLATION BY SIRT2</scope>
<scope>INTERACTION WITH EP300</scope>
</reference>
<reference key="92">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1038</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="93">
<citation type="journal article" date="2014" name="Mol. Cell" volume="56" first="261" last="274">
<title>Modification of ASC1 by UFM1 is crucial for ERalpha transactivation and breast cancer development.</title>
<authorList>
<person name="Yoo H.M."/>
<person name="Kang S.H."/>
<person name="Kim J.Y."/>
<person name="Lee J.E."/>
<person name="Seong M.W."/>
<person name="Lee S.W."/>
<person name="Ka S.H."/>
<person name="Sou Y.S."/>
<person name="Komatsu M."/>
<person name="Tanaka K."/>
<person name="Lee S.T."/>
<person name="Noh D.Y."/>
<person name="Baek S.H."/>
<person name="Jeon Y.J."/>
<person name="Chung C.H."/>
</authorList>
<dbReference type="PubMed" id="25219498"/>
<dbReference type="DOI" id="10.1016/j.molcel.2014.08.007"/>
</citation>
<scope>INTERACTION WITH TRIP4</scope>
</reference>
<reference key="94">
<citation type="journal article" date="2014" name="Nucleic Acids Res." volume="42" first="8433" last="8448">
<title>CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesis.</title>
<authorList>
<person name="Cazzalini O."/>
<person name="Sommatis S."/>
<person name="Tillhon M."/>
<person name="Dutto I."/>
<person name="Bachi A."/>
<person name="Rapp A."/>
<person name="Nardo T."/>
<person name="Scovassi A.I."/>
<person name="Necchi D."/>
<person name="Cardoso M.C."/>
<person name="Stivala L.A."/>
<person name="Prosperi E."/>
</authorList>
<dbReference type="PubMed" id="24939902"/>
<dbReference type="DOI" id="10.1093/nar/gku533"/>
</citation>
<scope>FUNCTION AS ACETYLTRANSFERASE OF PCNA</scope>
<scope>INTERACTION WITH PCNA</scope>
</reference>
<reference key="95">
<citation type="journal article" date="2014" name="Nucleic Acids Res." volume="42" first="11447" last="11461">
<title>Two ZNF509 (ZBTB49) isoforms induce cell-cycle arrest by activating transcription of p21/CDKN1A and RB upon exposure to genotoxic stress.</title>
<authorList>
<person name="Jeon B.N."/>
<person name="Kim M.K."/>
<person name="Yoon J.H."/>
<person name="Kim M.Y."/>
<person name="An H."/>
<person name="Noh H.J."/>
<person name="Choi W.I."/>
<person name="Koh D.I."/>
<person name="Hur M.W."/>
</authorList>
<dbReference type="PubMed" id="25245946"/>
<dbReference type="DOI" id="10.1093/nar/gku857"/>
</citation>
<scope>INTERACTION WITH ZBTB49</scope>
</reference>
<reference key="96">
<citation type="journal article" date="2015" name="Mol. Cell" volume="58" first="203" last="215">
<title>Intracellular crotonyl-CoA stimulates transcription through p300-catalyzed histone crotonylation.</title>
<authorList>
<person name="Sabari B.R."/>
<person name="Tang Z."/>
<person name="Huang H."/>
<person name="Yong-Gonzalez V."/>
<person name="Molina H."/>
<person name="Kong H.E."/>
<person name="Dai L."/>
<person name="Shimada M."/>
<person name="Cross J.R."/>
<person name="Zhao Y."/>
<person name="Roeder R.G."/>
<person name="Allis C.D."/>
</authorList>
<dbReference type="PubMed" id="25818647"/>
<dbReference type="DOI" id="10.1016/j.molcel.2015.02.029"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="97">
<citation type="journal article" date="2015" name="Nat. Immunol." volume="16" first="1215" last="1227">
<title>PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Mao D."/>
<person name="Roswit W.T."/>
<person name="Jin X."/>
<person name="Patel A.C."/>
<person name="Patel D.A."/>
<person name="Agapov E."/>
<person name="Wang Z."/>
<person name="Tidwell R.M."/>
<person name="Atkinson J.J."/>
<person name="Huang G."/>
<person name="McCarthy R."/>
<person name="Yu J."/>
<person name="Yun N.E."/>
<person name="Paessler S."/>
<person name="Lawson T.G."/>
<person name="Omattage N.S."/>
<person name="Brett T.J."/>
<person name="Holtzman M.J."/>
</authorList>
<dbReference type="PubMed" id="26479788"/>
<dbReference type="DOI" id="10.1038/ni.3279"/>
</citation>
<scope>INTERACTION WITH STAT1</scope>
</reference>
<reference key="98">
<citation type="journal article" date="2016" name="N. Engl. J. Med." volume="375" first="2165" last="2176">
<title>Multisystem anomalies in severe combined immunodeficiency with mutant BCL11B.</title>
<authorList>
<person name="Punwani D."/>
<person name="Zhang Y."/>
<person name="Yu J."/>
<person name="Cowan M.J."/>
<person name="Rana S."/>
<person name="Kwan A."/>
<person name="Adhikari A.N."/>
<person name="Lizama C.O."/>
<person name="Mendelsohn B.A."/>
<person name="Fahl S.P."/>
<person name="Chellappan A."/>
<person name="Srinivasan R."/>
<person name="Brenner S.E."/>
<person name="Wiest D.L."/>
<person name="Puck J.M."/>
</authorList>
<dbReference type="PubMed" id="27959755"/>
<dbReference type="DOI" id="10.1056/NEJMoa1509164"/>
</citation>
<scope>INTERACTION WITH BCL11B</scope>
</reference>
<reference key="99">
<citation type="journal article" date="2016" name="Sci. Rep." volume="6" first="26294" last="26294">
<title>Heat shock factor 1 mediates latent HIV reactivation.</title>
<authorList>
<person name="Pan X.Y."/>
<person name="Zhao W."/>
<person name="Zeng X.Y."/>
<person name="Lin J."/>
<person name="Li M.M."/>
<person name="Shen X.T."/>
<person name="Liu S.W."/>
</authorList>
<dbReference type="PubMed" id="27189267"/>
<dbReference type="DOI" id="10.1038/srep26294"/>
</citation>
<scope>INTERACTION WITH HSF1</scope>
</reference>
<reference key="100">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="5367" last="5372">
<title>Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha.</title>
<authorList>
<person name="Freedman S.J."/>
<person name="Sun Z.-Y.J."/>
<person name="Poy F."/>
<person name="Kung A.L."/>
<person name="Livingston D.M."/>
<person name="Wagner G."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="11959990"/>
<dbReference type="DOI" id="10.1073/pnas.082117899"/>
</citation>
<scope>STRUCTURE BY NMR OF 302-418 IN COMPLEX WITH HIF1A PEPTIDE AND ZINC IONS</scope>
</reference>
<reference key="101">
<citation type="journal article" date="2003" name="Nat. Struct. Biol." volume="10" first="504" last="512">
<title>Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2.</title>
<authorList>
<person name="Freedman S.J."/>
<person name="Sun Z.Y."/>
<person name="Kung A.L."/>
<person name="France D.S."/>
<person name="Wagner G."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="12778114"/>
<dbReference type="DOI" id="10.1038/nsb936"/>
</citation>
<scope>STRUCTURE BY NMR OF 323-423 IN COMPLEX WITH 216-259 OF CITED2 AND ZINC IONS</scope>
<scope>INTERACTION WITH CITED2</scope>
<scope>MUTAGENESIS OF LEU-344 AND LEU-345</scope>
</reference>
<reference key="102">
<citation type="journal article" date="2008" name="Nature" volume="451" first="846" last="850">
<title>The structural basis of protein acetylation by the p300/CBP transcriptional coactivator.</title>
<authorList>
<person name="Liu X."/>
<person name="Wang L."/>
<person name="Zhao K."/>
<person name="Thompson P.R."/>
<person name="Hwang Y."/>
<person name="Marmorstein R."/>
<person name="Cole P.A."/>
</authorList>
<dbReference type="PubMed" id="18273021"/>
<dbReference type="DOI" id="10.1038/nature06546"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 1287-1666 IN COMPLEX WITH LYS-COA</scope>
<scope>MUTAGENESIS OF THR-1357; SER-1396; TYR-1397; GLU-1505; ASP-1625 AND ASP-1628</scope>
</reference>
<reference key="103">
<citation type="journal article" date="2009" name="Structure" volume="17" first="202" last="210">
<title>Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation.</title>
<authorList>
<person name="Feng H."/>
<person name="Jenkins L.M.M."/>
<person name="Durell S.R."/>
<person name="Hayashi R."/>
<person name="Mazur S.J."/>
<person name="Cherry S."/>
<person name="Tropea J.E."/>
<person name="Miller M."/>
<person name="Wlodawer A."/>
<person name="Appella E."/>
<person name="Bai Y."/>
</authorList>
<dbReference type="PubMed" id="19217391"/>
<dbReference type="DOI" id="10.1016/j.str.2008.12.009"/>
</citation>
<scope>STRUCTURE BY NMR OF 1723-1812</scope>
<scope>INTERACTION WITH TP53</scope>
</reference>
<reference key="104">
<citation type="journal article" date="2012" name="Cell" volume="149" first="214" last="231">
<title>Histone recognition and large-scale structural analysis of the human bromodomain family.</title>
<authorList>
<person name="Filippakopoulos P."/>
<person name="Picaud S."/>
<person name="Mangos M."/>
<person name="Keates T."/>
<person name="Lambert J.P."/>
<person name="Barsyte-Lovejoy D."/>
<person name="Felletar I."/>
<person name="Volkmer R."/>
<person name="Muller S."/>
<person name="Pawson T."/>
<person name="Gingras A.C."/>
<person name="Arrowsmith C.H."/>
<person name="Knapp S."/>
</authorList>
<dbReference type="PubMed" id="22464331"/>
<dbReference type="DOI" id="10.1016/j.cell.2012.02.013"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.33 ANGSTROMS) OF 1040-1161</scope>
</reference>
<reference key="105">
<citation type="journal article" date="2013" name="Nat. Struct. Mol. Biol." volume="20" first="1040" last="1046">
<title>Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation.</title>
<authorList>
<person name="Delvecchio M."/>
<person name="Gaucher J."/>
<person name="Aguilar-Gurrieri C."/>
<person name="Ortega E."/>
<person name="Panne D."/>
</authorList>
<dbReference type="PubMed" id="23934153"/>
<dbReference type="DOI" id="10.1038/nsmb.2642"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 1043-1519 AND 1581-1666 OF MUTANT PHE-1467 IN COMPLEX WITH ZINC</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>AUTOACETYLATION</scope>
<scope>MUTAGENESIS OF PHE-1170; CYS-1204; GLU-1242; ASP-1399; TYR-1467 AND 1645-ARG-ARG-1646</scope>
</reference>
<reference key="106">
<citation type="journal article" date="2014" name="Biochemistry" volume="53" first="3415" last="3422">
<title>Structure of the p300 histone acetyltransferase bound to acetyl-coenzyme A and its analogues.</title>
<authorList>
<person name="Maksimoska J."/>
<person name="Segura-Pena D."/>
<person name="Cole P.A."/>
<person name="Marmorstein R."/>
</authorList>
<dbReference type="PubMed" id="24819397"/>
<dbReference type="DOI" id="10.1021/bi500380f"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) OF 1287-1664 OF MUTANT PHE-1467 IN COMPLEX WITH ACETYL-COA AND COENZYME A</scope>
</reference>
<reference key="107">
<citation type="journal article" date="2000" name="Nat. Genet." volume="24" first="300" last="303">
<title>Mutations truncating the EP300 acetylase in human cancers.</title>
<authorList>
<person name="Gayther S.A."/>
<person name="Batley S.J."/>
<person name="Linger L."/>
<person name="Bannister A."/>
<person name="Thorpe K."/>
<person name="Chin S.-F."/>
<person name="Daigo Y."/>
<person name="Russell P."/>
<person name="Wilson A."/>
<person name="Sowter H.M."/>
<person name="Delhanty J.D.A."/>
<person name="Ponder B.A.J."/>
<person name="Kouzarides T."/>
<person name="Caldas C."/>
</authorList>
<dbReference type="PubMed" id="10700188"/>
<dbReference type="DOI" id="10.1038/73536"/>
</citation>
<scope>VARIANTS PRO-827; GLY-1013; TYR-1650 AND GLN-2221</scope>
<scope>POSSIBLE INVOLVEMENT IN CANCER</scope>
</reference>
<reference key="108">
<citation type="journal article" date="2015" name="Clin. Genet." volume="87" first="148" last="154">
<title>Clinical and molecular characterization of Rubinstein-Taybi syndrome patients carrying distinct novel mutations of the EP300 gene.</title>
<authorList>
<person name="Negri G."/>
<person name="Milani D."/>
<person name="Colapietro P."/>
<person name="Forzano F."/>
<person name="Della Monica M."/>
<person name="Rusconi D."/>
<person name="Consonni L."/>
<person name="Caffi L.G."/>
<person name="Finelli P."/>
<person name="Scarano G."/>
<person name="Magnani C."/>
<person name="Selicorni A."/>
<person name="Spena S."/>
<person name="Larizza L."/>
<person name="Gervasini C."/>
</authorList>
<dbReference type="PubMed" id="24476420"/>
<dbReference type="DOI" id="10.1111/cge.12348"/>
</citation>
<scope>VARIANT ILE-1511</scope>
</reference>
<comment type="function">
<text evidence="17 27 33 42 48 51 56 58 63 69 72 73 78 82 83 87 89 90 91 98 101 108 114">Functions as histone acetyltransferase and regulates transcription via chromatin remodeling (PubMed:23415232, PubMed:23934153, PubMed:8945521). Acetylates all four core histones in nucleosomes. Histone acetylation gives an epigenetic tag for transcriptional activation (PubMed:23415232, PubMed:23934153, PubMed:8945521). Mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. Mediates acetylation of histone H3 at 'Lys-122' (H3K122ac), a modification that localizes at the surface of the histone octamer and stimulates transcription, possibly by promoting nucleosome instability. Mediates acetylation of histone H3 at 'Lys-27' (H3K27ac) (PubMed:23911289). Also functions as acetyltransferase for nonhistone targets. Acetylates 'Lys-131' of ALX1 and acts as its coactivator (PubMed:12929931). Acetylates SIRT2 and is proposed to indirectly increase the transcriptional activity of TP53 through acetylation and subsequent attenuation of SIRT2 deacetylase function (PubMed:18722353). Acetylates HDAC1 leading to its inactivation and modulation of transcription (PubMed:16762839). Acts as a TFAP2A-mediated transcriptional coactivator in presence of CITED2 (PubMed:12586840). Plays a role as a coactivator of NEUROD1-dependent transcription of the secretin and p21 genes and controls terminal differentiation of cells in the intestinal epithelium. Promotes cardiac myocyte enlargement. Can also mediate transcriptional repression. Acetylates FOXO1 and enhances its transcriptional activity (PubMed:15890677). Acetylates BCL6 wich disrupts its ability to recruit histone deacetylases and hinders its transcriptional repressor activity (PubMed:12402037). Participates in CLOCK or NPAS2-regulated rhythmic gene transcription; exhibits a circadian association with CLOCK or NPAS2, correlating with increase in PER1/2 mRNA and histone H3 acetylation on the PER1/2 promoter (PubMed:14645221). Acetylates MTA1 at 'Lys-626' which is essential for its transcriptional coactivator activity (PubMed:16617102). Acetylates XBP1 isoform 2; acetylation increases protein stability of XBP1 isoform 2 and enhances its transcriptional activity (PubMed:20955178). Acetylates PCNA; acetylation promotes removal of chromatin-bound PCNA and its degradation during nucleotide excision repair (NER) (PubMed:24939902). Acetylates MEF2D (PubMed:21030595). In addition to protein acetyltransferase, can use different acyl-CoA substrates, such as (2E)-butenoyl-CoA (crotonyl-CoA), butanoyl-CoA (butyryl-CoA) or propanoyl-CoA (propionyl-CoA), and is able to mediate protein crotonylation, butyrylation or propionylation, respectively (PubMed:25818647, PubMed:17267393). Acts as a histone crotonyltransferase; crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors (PubMed:25818647). Histone crotonyltransferase activity is dependent on the concentration of (2E)-butenoyl-CoA (crotonyl-CoA) substrate and such activity is weak when (E)-but-2-enoyl-CoA (crotonyl-CoA) concentration is low (PubMed:25818647). Also acts as a histone butyryltransferase; butyrylation marks active promoters (PubMed:17267393).</text>
</comment>
<comment type="function">
<text evidence="24 31">(Microbial infection) In case of HIV-1 infection, it is recruited by the viral protein Tat. Regulates Tat's transactivating activity and may help inducing chromatin remodeling of proviral genes. Binds to and may be involved in the transforming capacity of the adenovirus E1A protein.</text>
</comment>
<comment type="catalytic activity">
<text evidence="89 91 108">Acetyl-CoA + [protein]-L-lysine = CoA + [protein]-N(6)-acetyl-L-lysine.</text>
</comment>
<comment type="catalytic activity">
<text evidence="101">(2E)-butenoyl-CoA + [protein]-L-lysine = CoA + [protein]-N(6)-(2E)-butenoyl-L-lysine.</text>
</comment>
<comment type="catalytic activity">
<text evidence="17">Butanoyl-CoA + [protein]-L-lysine = CoA + [protein]-N(6)-butanoyl-L-lysine.</text>
</comment>
<comment type="catalytic activity">
<text evidence="78">Propanoyl-CoA + [protein]-L-lysine = CoA + [protein]-N(6)-propanoyl-L-lysine.</text>
</comment>
<comment type="subunit">
<text evidence="17 24 26 28 29 30 31 32 33 35 36 37 38 39 40 41 42 43 44 45 46 47 49 50 51 53 54 55 56 57 58 59 60 62 63 64 65 68 69 70 71 72 74 75 77 79 80 84 85 86 88 92 93 94 95 99 100 102 103 104 106 107 109 110 111 112">Interacts with phosphorylated CREB1. Interacts with HIF1A; the interaction is stimulated in response to hypoxia and inhibited by CITED2. Interacts (via N-terminus) with TFAP2A (via N-terminus); the interaction requires CITED2. Interacts (via CH1 domain) with CITED2 (via C-terminus). Interacts with CITED1 (unphosphorylated form preferentially and via C-terminus). Interacts with ESR1; the interaction is estrogen-dependent and enhanced by CITED1. Interacts with DTX1, EID1, ELF3, FEN1, LEF1, NCOA1, NCOA6, NR3C1, PCAF, PELP1, PRDM6, SP1, SP3, SPIB, SRY, TCF7L2, TP53, DDX5, DDX17, SATB1, SRCAP, TTC5, JMY and TRERF1. The TAZ-type 1 domain interacts with HIF1A. Probably part of a complex with HIF1A and CREBBP. Part of a complex containing CARM1 and NCOA2/GRIP1. Interacts with ING4 and this interaction may be indirect. Interacts with ING5. Interacts with the C-terminal region of CITED4. Non-sumoylated EP300 preferentially interacts with SENP3. Interacts with SS18L1/CREST. Interacts with ALX1 (via homeobox domain). Interacts with NEUROD1; the interaction is inhibited by NR0B2. Interacts with TCF3. Interacts (via CREB-binding domain) with MYOCD (via C-terminus). Binds to HIPK2. Interacts with ROCK2 and PPARG. Forms a complex made of CDK9, CCNT1/cyclin-T1, EP300 and GATA4 that stimulates hypertrophy in cardiomyocytes. Interacts with IRF1 and this interaction enhances acetylation of p53/TP53 and stimulation of its activity. Interacts with FOXO1; the interaction acetylates FOXO1 and enhances its transcriptional activity. Interacts with ALKBH4 and DDIT3/CHOP. Interacts with KLF15. Interacts with CEBPB and RORA. Interacts with HTLV-1 Tax and p30II. Interacts with and acetylates HIV-1 Tat. Interacts with NPAS2, ARNTL/BMAL1 and CLOCK. Interacts with SIRT2 isoform 1, isoform 2 and isoform 5. Interacts with MTA1. Interacts with HDAC4 and HDAC5 in the presence of TFAP2C (PubMed:10545121, PubMed:10722728, PubMed:10823961, PubMed:11073989, PubMed:11073990, PubMed:11080476, PubMed:11349124, PubMed:11430825, PubMed:11463834, PubMed:11481323, PubMed:11518699, PubMed:11559821, PubMed:11564735, PubMed:11581164, PubMed:11581372, PubMed:11701890, PubMed:11744733, PubMed:11864910, PubMed:11959990, PubMed:11997499, PubMed:12446687, PubMed:12527917, PubMed:12586840, PubMed:12750254, PubMed:12778114, PubMed:12837748, PubMed:12929931, PubMed:14605447, PubMed:14645221, PubMed:14716005, PubMed:14752053, PubMed:15075319, PubMed:15186775, PubMed:15297880, PubMed:15509808, PubMed:15731352, PubMed:15890677, PubMed:16478997, PubMed:16574662, PubMed:16617102, PubMed:16864582, PubMed:17226766, PubMed:17872950, PubMed:18273021, PubMed:19217391, PubMed:19680224, PubMed:20081228, PubMed:23145062, PubMed:23999430, PubMed:24177535, PubMed:24413532, PubMed:8684459, PubMed:8917528, PubMed:9528808, PubMed:9590696, PubMed:9862959, PubMed:9887100). Interacts with TRIP4 (PubMed:25219498). Directly interacts with ZBTB49; this interaction leads to synergistic transactivation of CDKN1A (PubMed:25245946). Interacts with NR4A3 (By similarity). Interacts with ZNF451 (PubMed:24324267). Interacts with ATF5; EP300 is required for ATF5 and CEBPB interaction and DNA binding (By similarity). Interacts with HSF1 (PubMed:27189267). Interacts with ZBTB48/TZAP (PubMed:24382891). Interacts with STAT1; the interaction is enhanced upon IFN-gamma stimulation (PubMed:26479788). Interacts with HNRNPU (via C-terminus); this interaction enhances DNA-binding of HNRNPU to nuclear scaffold/matrix attachment region (S/MAR) elements (PubMed:11909954). Interacts with BCL11B (PubMed:27959755, PubMed:16809611).</text>
</comment>
<comment type="subunit">
<text evidence="34">(Microbial infection) Interacts with human adenovirus 5 E1A protein; this interaction stimulates the acetylation of RB1 by recruiting EP300 and RB1 into a multimeric-protein complex.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-617698">
<id>P03070</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-2603114">
<id>P03255</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-6859460">
<id>P03255-2</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-6947456">
<id>P03259</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-8637516">
<id>Q9NXW9</id>
<label>ALKBH4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-1048805">
<id>P27695</id>
<label>APEX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-540797">
<id>Q9UBL3</id>
<label>ASH2L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-2875359">
<id>Q8WXX7</id>
<label>AUTS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-11296047">
<id>K4P3M7</id>
<label>BICP0</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-711221">
<id>Q9NPI1</id>
<label>BRD7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-375096">
<id>P24941</id>
<label>CDK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-937732">
<id>Q99967</id>
<label>CITED2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-1050386">
<id>P61201</id>
<label>COPS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-711855">
<id>P16220</id>
<label>CREB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-2291098">
<id>Q01147</id>
<label>Creb1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-351962">
<id>P17844</id>
<label>DDX5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-7028618">
<id>P03122</id>
<label>E2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-7136851">
<id>P06422</id>
<label>E2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-7010629">
<id>P06790</id>
<label>E2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-739737">
<id>Q01844</id>
<label>EWSR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-400434">
<id>P35637</id>
<label>FUS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-389564">
<id>Q00403</id>
<label>GTF2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-447269">
<id>Q16665</id>
<label>HIF1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>20</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-298954">
<id>Q61221</id>
<label>Hif1a</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-348345">
<id>Q9H2X6</id>
<label>HIPK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-866001">
<id>Q9QXM1</id>
<label>Jmy</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-477430">
<id>Q92831</id>
<label>KAT2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-356392">
<id>P55209</id>
<label>NAP1L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-494844">
<id>O60934</id>
<label>NBN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-81196">
<id>Q9Y6Q9</id>
<label>NCOA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-1167176">
<id>P20265</id>
<label>POU3F2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-1105153">
<id>Q96KQ4</id>
<label>PPP1R13B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-5550163">
<id>Q8WUF5</id>
<label>PPP1R13L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-925990">
<id>Q13761</id>
<label>RUNX3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
<label>SIRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-456291">
<id>Q13309</id>
<label>SKP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-1045459">
<id>O95863</id>
<label>SNAI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-1186478">
<id>P42226</id>
<label>STAT6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-6164389">
<id>P04608</id>
<label>tat</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-3922312">
<id>Q9UL17</id>
<label>TBX21</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-749995">
<id>P56279</id>
<label>TCL1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-347351">
<id>P05549</id>
<label>TFAP2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>20</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-77642">
<id>Q13625</id>
<label>TP53BP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-389606">
<id>O15350</id>
<label>TP73</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-286357">
<id>P11473</id>
<label>VDR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447295"/>
<interactant intactId="EBI-354065">
<id>P67809</id>
<label>YBX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="56">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="56 58 71">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="58 101">Chromosome</location>
</subcellularLocation>
<text evidence="56 101">Localizes to active chromatin: Colocalizes with histone H3 acetylated and/or crotonylated at 'Lys-18' (H3K18ac and H3K18cr, respectively) (PubMed:25818647). In the presence of ALX1 relocalizes from the cytoplasm to the nucleus. Colocalizes with ROCK2 in the nucleus (PubMed:12929931).</text>
</comment>
<comment type="domain">
<text>The CRD1 domain (cell cycle regulatory domain 1) mediates transcriptional repression of a subset of p300 responsive genes; it can be de-repressed by CDKN1A/p21WAF1 at least at some promoters. It conatins sumoylation and acetylation sites and the same lysine residues may be targeted for the respective modifications. It is proposed that deacetylation by SIRT1 allows sumoylation leading to suppressed activity.</text>
</comment>
<comment type="PTM">
<text evidence="61 66 76 83 91 93">Acetylated on Lys at up to 17 positions by intermolecular autocatalysis. Deacetylated in the transcriptional repression domain (CRD1) by SIRT1, preferentially at Lys-1020. Deacetylated by SIRT2, preferentially at Lys-418, Lys-423, Lys-1542, Lys-1546, Lys-1549, Lys-1699, Lys-1704 and Lys-1707.</text>
</comment>
<comment type="PTM">
<text evidence="42 68">Citrullinated at Arg-2142 by PADI4, which impairs methylation by CARM1 and promotes interaction with NCOA2/GRIP1.</text>
</comment>
<comment type="PTM">
<text evidence="42 68">Methylated at Arg-580 and Arg-604 in the KIX domain by CARM1, which blocks association with CREB, inhibits CREB signaling and activates apoptotic response. Also methylated at Arg-2142 by CARM1, which impairs interaction with NCOA2/GRIP1.</text>
</comment>
<comment type="PTM">
<text evidence="52 85">Sumoylated; sumoylation in the transcriptional repression domain (CRD1) mediates transcriptional repression. Desumoylated by SENP3 through the removal of SUMO2 and SUMO3.</text>
</comment>
<comment type="PTM">
<text>Probable target of ubiquitination by FBXO3, leading to rapid proteasome-dependent degradation.</text>
</comment>
<comment type="PTM">
<text evidence="37 49 71 81">Phosphorylated by HIPK2 in a RUNX1-dependent manner. This phosphorylation that activates EP300 happens when RUNX1 is associated with DNA and CBFB. Phosphorylated by ROCK2 and this enhances its activity. Phosphorylation at Ser-89 by AMPK reduces interaction with nuclear receptors, such as PPARG.</text>
</comment>
<comment type="disease">
<text>Defects in EP300 may play a role in epithelial cancer.</text>
</comment>
<comment type="disease">
<text>Chromosomal aberrations involving EP300 may be a cause of acute myeloid leukemias. Translocation t(8;22)(p11;q13) with KAT6A.</text>
</comment>
<comment type="disease" evidence="67">
<disease id="DI-02976">
<name>Rubinstein-Taybi syndrome 2</name>
<acronym>RSTS2</acronym>
<description>A disorder characterized by craniofacial abnormalities, postnatal growth deficiency, broad thumbs, broad big toes, mental retardation and a propensity for development of malignancies. Some individuals with RSTS2 have less severe mental impairment, more severe microcephaly, and a greater degree of changes in facial bone structure than RSTS1 patients.</description>
<dbReference type="MIM" id="613684"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/P300ID97.html"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/P300/CBP"/>
<text>P300/CBP entry</text>
</comment>
<dbReference type="EC" id="2.3.1.48" evidence="89 91 108"/>
<dbReference type="EC" id="2.3.1.-" evidence="78 101"/>
<dbReference type="EMBL" id="U01877">
<property type="protein sequence ID" value="AAA18639.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL080243">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL096765">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL035658">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471095">
<property type="protein sequence ID" value="EAW60408.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14010.1"/>
<dbReference type="PIR" id="A54277">
<property type="entry name" value="A54277"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001420.2">
<property type="nucleotide sequence ID" value="NM_001429.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.517517"/>
<dbReference type="UniGene" id="Hs.655211"/>
<dbReference type="PDB" id="1L3E">
<property type="method" value="NMR"/>
<property type="chains" value="B=323-423"/>
</dbReference>
<dbReference type="PDB" id="1P4Q">
<property type="method" value="NMR"/>
<property type="chains" value="B=323-423"/>
</dbReference>
<dbReference type="PDB" id="2K8F">
<property type="method" value="NMR"/>
<property type="chains" value="A=1723-1812"/>
</dbReference>
<dbReference type="PDB" id="2MH0">
<property type="method" value="NMR"/>
<property type="chains" value="B=1723-1812"/>
</dbReference>
<dbReference type="PDB" id="2MZD">
<property type="method" value="NMR"/>
<property type="chains" value="A=1723-1812"/>
</dbReference>
<dbReference type="PDB" id="3BIY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1287-1666"/>
</dbReference>
<dbReference type="PDB" id="3I3J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.33"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J/K/L=1040-1161"/>
</dbReference>
<dbReference type="PDB" id="3IO2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1723-1836"/>
</dbReference>
<dbReference type="PDB" id="3P57">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.19"/>
<property type="chains" value="P=1726-1835"/>
</dbReference>
<dbReference type="PDB" id="3T92">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=1723-1818"/>
</dbReference>
<dbReference type="PDB" id="4BHW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=1043-1519, A/B=1581-1666"/>
</dbReference>
<dbReference type="PDB" id="4PZR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1287-1664"/>
</dbReference>
<dbReference type="PDB" id="4PZS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.94"/>
<property type="chains" value="A=1287-1664"/>
</dbReference>
<dbReference type="PDB" id="4PZT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=1287-1664"/>
</dbReference>
<dbReference type="PDB" id="5BT3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.05"/>
<property type="chains" value="A=1048-1161"/>
</dbReference>
<dbReference type="PDB" id="5KJ2">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=1287-1522, A=1555-1666"/>
</dbReference>
<dbReference type="PDB" id="5LKT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.04"/>
<property type="chains" value="A=1043-1519, A=1581-1666"/>
</dbReference>
<dbReference type="PDB" id="5LKU">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A=1043-1519, A=1581-1666"/>
</dbReference>
<dbReference type="PDB" id="5LKX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.52"/>
<property type="chains" value="A=1043-1519, A=1581-1666"/>
</dbReference>
<dbReference type="PDB" id="5LKZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1043-1519, A=1581-1666"/>
</dbReference>
<dbReference type="PDB" id="5LPK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B/C/D/E/F/G=1040-1161"/>
</dbReference>
<dbReference type="PDB" id="5LPM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A/B=1048-1161"/>
</dbReference>
<dbReference type="PDB" id="5NU5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A/B=1048-1161"/>
</dbReference>
<dbReference type="PDBsum" id="1L3E"/>
<dbReference type="PDBsum" id="1P4Q"/>
<dbReference type="PDBsum" id="2K8F"/>
<dbReference type="PDBsum" id="2MH0"/>
<dbReference type="PDBsum" id="2MZD"/>
<dbReference type="PDBsum" id="3BIY"/>
<dbReference type="PDBsum" id="3I3J"/>
<dbReference type="PDBsum" id="3IO2"/>
<dbReference type="PDBsum" id="3P57"/>
<dbReference type="PDBsum" id="3T92"/>
<dbReference type="PDBsum" id="4BHW"/>
<dbReference type="PDBsum" id="4PZR"/>
<dbReference type="PDBsum" id="4PZS"/>
<dbReference type="PDBsum" id="4PZT"/>
<dbReference type="PDBsum" id="5BT3"/>
<dbReference type="PDBsum" id="5KJ2"/>
<dbReference type="PDBsum" id="5LKT"/>
<dbReference type="PDBsum" id="5LKU"/>
<dbReference type="PDBsum" id="5LKX"/>
<dbReference type="PDBsum" id="5LKZ"/>
<dbReference type="PDBsum" id="5LPK"/>
<dbReference type="PDBsum" id="5LPM"/>
<dbReference type="PDBsum" id="5NU5"/>
<dbReference type="DisProt" id="DP00633"/>
<dbReference type="ProteinModelPortal" id="Q09472"/>
<dbReference type="SMR" id="Q09472"/>
<dbReference type="BioGrid" id="108347">
<property type="interactions" value="495"/>
</dbReference>
<dbReference type="CORUM" id="Q09472"/>
<dbReference type="DIP" id="DIP-257N"/>
<dbReference type="IntAct" id="Q09472">
<property type="interactions" value="199"/>
</dbReference>
<dbReference type="MINT" id="MINT-104535"/>
<dbReference type="STRING" id="9606.ENSP00000263253"/>
<dbReference type="BindingDB" id="Q09472"/>
<dbReference type="ChEMBL" id="CHEMBL3784"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2735"/>
<dbReference type="iPTMnet" id="Q09472"/>
<dbReference type="PhosphoSitePlus" id="Q09472"/>
<dbReference type="BioMuta" id="EP300"/>
<dbReference type="DMDM" id="223590203"/>
<dbReference type="EPD" id="Q09472"/>
<dbReference type="MaxQB" id="Q09472"/>
<dbReference type="PaxDb" id="Q09472"/>
<dbReference type="PeptideAtlas" id="Q09472"/>
<dbReference type="PRIDE" id="Q09472"/>
<dbReference type="Ensembl" id="ENST00000263253">
<property type="protein sequence ID" value="ENSP00000263253"/>
<property type="gene ID" value="ENSG00000100393"/>
</dbReference>
<dbReference type="GeneID" id="2033"/>
<dbReference type="KEGG" id="hsa:2033"/>
<dbReference type="UCSC" id="uc003azl.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2033"/>
<dbReference type="DisGeNET" id="2033"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000100393.10"/>
<dbReference type="GeneCards" id="EP300"/>
<dbReference type="GeneReviews" id="EP300"/>
<dbReference type="H-InvDB" id="HIX0203186"/>
<dbReference type="HGNC" id="HGNC:3373">
<property type="gene designation" value="EP300"/>
</dbReference>
<dbReference type="HPA" id="CAB000146"/>
<dbReference type="HPA" id="HPA003128"/>
<dbReference type="HPA" id="HPA004112"/>
<dbReference type="MalaCards" id="EP300"/>
<dbReference type="MIM" id="602700">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="613684">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q09472"/>
<dbReference type="OpenTargets" id="ENSG00000100393"/>
<dbReference type="Orphanet" id="353284">
<property type="disease" value="Rubinstein-Taybi syndrome due to EP300 haploinsufficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27807"/>
<dbReference type="eggNOG" id="KOG1778">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5076">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119206"/>
<dbReference type="HOGENOM" id="HOG000111353"/>
<dbReference type="HOVERGEN" id="HBG000185"/>
<dbReference type="InParanoid" id="Q09472"/>
<dbReference type="KO" id="K04498"/>
<dbReference type="OMA" id="GQVSNPP"/>
<dbReference type="OrthoDB" id="EOG091G0L04"/>
<dbReference type="PhylomeDB" id="Q09472"/>
<dbReference type="TreeFam" id="TF101097"/>
<dbReference type="BRENDA" id="2.3.1.48">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1234158">
<property type="pathway name" value="Regulation of gene expression by Hypoxia-inducible Factor"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1368082">
<property type="pathway name" value="RORA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1368108">
<property type="pathway name" value="BMAL1:CLOCK,NPAS2 activates circadian gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-156711">
<property type="pathway name" value="Polo-like kinase mediated events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1912408">
<property type="pathway name" value="Pre-NOTCH Transcription and Translation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1989781">
<property type="pathway name" value="PPARA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-201722">
<property type="pathway name" value="Formation of the beta-catenin:TCF transactivating complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2122947">
<property type="pathway name" value="NOTCH1 Intracellular Domain Regulates Transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2197563">
<property type="pathway name" value="NOTCH2 intracellular domain regulates transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2644606">
<property type="pathway name" value="Constitutive Signaling by NOTCH1 PEST Domain Mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2894862">
<property type="pathway name" value="Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3134973">
<property type="pathway name" value="LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3214847">
<property type="pathway name" value="HATs acetylate histones"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3371568">
<property type="pathway name" value="Attenuation phase"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381340">
<property type="pathway name" value="Transcriptional regulation of white adipocyte differentiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5250924">
<property type="pathway name" value="B-WICH complex positively regulates rRNA expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5617472">
<property type="pathway name" value="Activation of anterior HOX genes in hindbrain development during early embryogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5621575">
<property type="pathway name" value="CD209 (DC-SIGN) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689901">
<property type="pathway name" value="Metalloprotease DUBs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6781823">
<property type="pathway name" value="Formation of TC-NER Pre-Incision Complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6781827">
<property type="pathway name" value="Transcription-Coupled Nucleotide Excision Repair (TC-NER)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6782135">
<property type="pathway name" value="Dual incision in TC-NER"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6782210">
<property type="pathway name" value="Gap-filling DNA repair synthesis and ligation in TC-NER"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804114">
<property type="pathway name" value="TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804758">
<property type="pathway name" value="Regulation of TP53 Activity through Acetylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804760">
<property type="pathway name" value="Regulation of TP53 Activity through Methylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811555">
<property type="pathway name" value="PI5P Regulates TP53 Acetylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866907">
<property type="pathway name" value="Activation of the TFAP2 (AP-2) family of transcription factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8936459">
<property type="pathway name" value="RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939243">
<property type="pathway name" value="RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8941856">
<property type="pathway name" value="RUNX3 regulates NOTCH signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8941858">
<property type="pathway name" value="Regulation of RUNX3 expression and activity"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8951936">
<property type="pathway name" value="RUNX3 regulates p14-ARF"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-918233">
<property type="pathway name" value="TRAF3-dependent IRF activation pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933541">
<property type="pathway name" value="TRAF6 mediated IRF7 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983231">
<property type="pathway name" value="Factors involved in megakaryocyte development and platelet production"/>
</dbReference>
<dbReference type="SignaLink" id="Q09472"/>
<dbReference type="SIGNOR" id="Q09472"/>
<dbReference type="ChiTaRS" id="EP300">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q09472"/>
<dbReference type="GeneWiki" id="EP300"/>
<dbReference type="GenomeRNAi" id="2033"/>
<dbReference type="PRO" id="PR:Q09472"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 22"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000100393"/>
<dbReference type="CleanEx" id="HS_EP300"/>
<dbReference type="ExpressionAtlas" id="Q09472">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q09472">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005694">
<property type="term" value="C:chromosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000123">
<property type="term" value="C:histone acetyltransferase complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription factor complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016407">
<property type="term" value="F:acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033613">
<property type="term" value="F:activating transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050681">
<property type="term" value="F:androgen receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008013">
<property type="term" value="F:beta-catenin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031490">
<property type="term" value="F:chromatin DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001047">
<property type="term" value="F:core promoter binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003684">
<property type="term" value="F:damaged DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004402">
<property type="term" value="F:histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0140069">
<property type="term" value="F:histone butyryltransferase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0140068">
<property type="term" value="F:histone crotonyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004468">
<property type="term" value="F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035257">
<property type="term" value="F:nuclear hormone receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002039">
<property type="term" value="F:p53 binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0140065">
<property type="term" value="F:peptide butyryltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034212">
<property type="term" value="F:peptide N-acetyltransferase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0061733">
<property type="term" value="F:peptide-lysine-N-acetyltransferase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0097157">
<property type="term" value="F:pre-mRNA intronic binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0061920">
<property type="term" value="F:protein propionyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001102">
<property type="term" value="F:RNA polymerase II activating transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000979">
<property type="term" value="F:RNA polymerase II core promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097677">
<property type="term" value="F:STAT family protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016746">
<property type="term" value="F:transferase activity, transferring acyl groups"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0009887">
<property type="term" value="P:animal organ morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030183">
<property type="term" value="P:B cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904837">
<property type="term" value="P:beta-catenin-TCF complex assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034644">
<property type="term" value="P:cellular response to UV"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007623">
<property type="term" value="P:circadian rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006977">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045444">
<property type="term" value="P:fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016573">
<property type="term" value="P:histone acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043969">
<property type="term" value="P:histone H2B acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043967">
<property type="term" value="P:histone H4 acetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018393">
<property type="term" value="P:internal peptidyl-lysine acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006475">
<property type="term" value="P:internal protein amino acid acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042771">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030324">
<property type="term" value="P:lung development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010742">
<property type="term" value="P:macrophage derived foam cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035855">
<property type="term" value="P:megakaryocyte development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0018076">
<property type="term" value="P:N-terminal peptidyl-lysine acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007399">
<property type="term" value="P:nervous system development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007219">
<property type="term" value="P:Notch signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0140067">
<property type="term" value="P:peptidyl-lysine butyrylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0140066">
<property type="term" value="P:peptidyl-lysine crotonylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061921">
<property type="term" value="P:peptidyl-lysine propionylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030220">
<property type="term" value="P:platelet formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043923">
<property type="term" value="P:positive regulation by host of viral transcription"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051091">
<property type="term" value="P:positive regulation of DNA binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045815">
<property type="term" value="P:positive regulation of gene expression, epigenetic"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032092">
<property type="term" value="P:positive regulation of protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006990">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032481">
<property type="term" value="P:positive regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006473">
<property type="term" value="P:protein acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031648">
<property type="term" value="P:protein destabilization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060765">
<property type="term" value="P:regulation of androgen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010506">
<property type="term" value="P:regulation of autophagy"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051726">
<property type="term" value="P:regulation of cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1900034">
<property type="term" value="P:regulation of cellular response to heat"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045652">
<property type="term" value="P:regulation of megakaryocyte differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0061418">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter in response to hypoxia"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090043">
<property type="term" value="P:regulation of tubulin deacetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043627">
<property type="term" value="P:response to estrogen"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007519">
<property type="term" value="P:skeletal muscle tissue development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001756">
<property type="term" value="P:somitogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006283">
<property type="term" value="P:transcription-coupled nucleotide-excision repair"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd15802">
<property type="entry name" value="RING_CBP-p300"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.1630.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.1020.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.920.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001487">
<property type="entry name" value="Bromodomain"/>
</dbReference>
<dbReference type="InterPro" id="IPR036427">
<property type="entry name" value="Bromodomain-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR018359">
<property type="entry name" value="Bromodomain_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR031162">
<property type="entry name" value="CBP_P300_HAT"/>
</dbReference>
<dbReference type="InterPro" id="IPR013178">
<property type="entry name" value="Histone_AcTrfase_Rtt109/CBP"/>
</dbReference>
<dbReference type="InterPro" id="IPR003101">
<property type="entry name" value="KIX_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036529">
<property type="entry name" value="KIX_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR009110">
<property type="entry name" value="Nuc_rcpt_coact"/>
</dbReference>
<dbReference type="InterPro" id="IPR014744">
<property type="entry name" value="Nuc_rcpt_coact_CREBbp"/>
</dbReference>
<dbReference type="InterPro" id="IPR037073">
<property type="entry name" value="Nuc_rcpt_coact_CREBbp_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR010303">
<property type="entry name" value="RING_CBP-p300"/>
</dbReference>
<dbReference type="InterPro" id="IPR035898">
<property type="entry name" value="TAZ_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000197">
<property type="entry name" value="Znf_TAZ"/>
</dbReference>
<dbReference type="InterPro" id="IPR000433">
<property type="entry name" value="Znf_ZZ"/>
</dbReference>
<dbReference type="Pfam" id="PF00439">
<property type="entry name" value="Bromodomain"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09030">
<property type="entry name" value="Creb_binding"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF06001">
<property type="entry name" value="DUF902"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08214">
<property type="entry name" value="HAT_KAT11"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02172">
<property type="entry name" value="KIX"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02135">
<property type="entry name" value="zf-TAZ"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00569">
<property type="entry name" value="ZZ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00503">
<property type="entry name" value="BROMODOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00297">
<property type="entry name" value="BROMO"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01250">
<property type="entry name" value="KAT11"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00551">
<property type="entry name" value="ZnF_TAZ"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00291">
<property type="entry name" value="ZnF_ZZ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47040">
<property type="entry name" value="SSF47040"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47370">
<property type="entry name" value="SSF47370"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57933">
<property type="entry name" value="SSF57933"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF69125">
<property type="entry name" value="SSF69125"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00633">
<property type="entry name" value="BROMODOMAIN_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50014">
<property type="entry name" value="BROMODOMAIN_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51727">
<property type="entry name" value="CBP_P300_HAT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50952">
<property type="entry name" value="KIX"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50134">
<property type="entry name" value="ZF_TAZ"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS01357">
<property type="entry name" value="ZF_ZZ_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50135">
<property type="entry name" value="ZF_ZZ_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0012">Acyltransferase</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0103">Bromodomain</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0164">Citrullination</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="initiator methionine" description="Removed" evidence="11 14">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Histone acetyltransferase p300" id="PRO_0000211193">
<location>
<begin position="2"/>
<end position="2414"/>
</location>
</feature>
<feature type="domain" description="KIX" evidence="22">
<location>
<begin position="566"/>
<end position="645"/>
</location>
</feature>
<feature type="domain" description="Bromo" evidence="19">
<location>
<begin position="1067"/>
<end position="1139"/>
</location>
</feature>
<feature type="domain" description="CBP/p300-type HAT" evidence="23">
<location>
<begin position="1287"/>
<end position="1663"/>
</location>
</feature>
<feature type="zinc finger region" description="TAZ-type 1" evidence="20">
<location>
<begin position="331"/>
<end position="417"/>
</location>
</feature>
<feature type="zinc finger region" description="ZZ-type" evidence="21">
<location>
<begin position="1664"/>
<end position="1707"/>
</location>
</feature>
<feature type="zinc finger region" description="TAZ-type 2" evidence="20">
<location>
<begin position="1728"/>
<end position="1809"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with RORA" evidence="111">
<location>
<begin position="2"/>
<end position="149"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with ALX1" evidence="56">
<location>
<begin position="2"/>
<end position="139"/>
</location>
</feature>
<feature type="region of interest" description="CRD1; mediates transcriptional repression">
<location>
<begin position="1017"/>
<end position="1029"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with histone" evidence="80">
<location>
<begin position="1397"/>
<end position="1399"/>
</location>
</feature>
<feature type="region of interest" description="Acetyl-CoA binding" evidence="97">
<location>
<begin position="1398"/>
<end position="1400"/>
</location>
</feature>
<feature type="region of interest" description="Acetyl-CoA binding" evidence="97">
<location>
<begin position="1410"/>
<end position="1411"/>
</location>
</feature>
<feature type="region of interest" description="Binding region for E1A adenovirus">
<location>
<begin position="1572"/>
<end position="1818"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with HTLV-1 Tax">
<location>
<begin position="2003"/>
<end position="2212"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with NCOA2" evidence="68">
<location>
<begin position="2041"/>
<end position="2240"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="18">
<location>
<begin position="11"/>
<end position="17"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="797"/>
<end position="800"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="1519"/>
<end position="1526"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="2066"/>
<end position="2069"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="2190"/>
<end position="2195"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1">
<location>
<position position="347"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1">
<location>
<position position="351"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1">
<location>
<position position="364"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1">
<location>
<position position="369"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2">
<location>
<position position="378"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2">
<location>
<position position="382"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2">
<location>
<position position="388"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2">
<location>
<position position="393"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3">
<location>
<position position="402"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3">
<location>
<position position="406"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3">
<location>
<position position="411"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3">
<location>
<position position="414"/>
</location>
</feature>
<feature type="binding site" description="Acetyl-CoA; via carbonyl oxygen" evidence="97">
<location>
<position position="1457"/>
</location>
</feature>
<feature type="binding site" description="Acetyl-CoA" evidence="97">
<location>
<position position="1462"/>
</location>
</feature>
<feature type="binding site" description="Acetyl-CoA" evidence="97">
<location>
<position position="1466"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KAT6A-EP300 and EP300-KAT6A">
<location>
<begin position="31"/>
<end position="32"/>
</location>
</feature>
<feature type="site" description="Interaction with NCOA2">
<location>
<position position="2088"/>
</location>
</feature>
<feature type="site" description="Interaction with NCOA2">
<location>
<position position="2142"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="11 14">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by AMPK" evidence="37 71">
<location>
<position position="89"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="83">
<location>
<position position="418"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="83">
<location>
<position position="423"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="499"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylated arginine; by CARM1" evidence="42">
<location>
<position position="580"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylated arginine; by CARM1" evidence="42">
<location>
<position position="604"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="636"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="977"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="66">
<location>
<position position="1020"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="66">
<location>
<position position="1024"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13 15 16">
<location>
<position position="1038"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="17">
<location>
<position position="1180"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="76">
<location>
<position position="1336"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="76">
<location>
<position position="1473"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by autocatalysis" evidence="61">
<location>
<position position="1499"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12 83">
<location>
<position position="1542"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12 83">
<location>
<position position="1546"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by autocatalysis" evidence="61 83">
<location>
<position position="1549"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by autocatalysis" evidence="12 61">
<location>
<position position="1554"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="1555"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12 61">
<location>
<position position="1558"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by autocatalysis" evidence="12 61">
<location>
<position position="1560"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="1583"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="83">
<location>
<position position="1699"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="83">
<location>
<position position="1704"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="83">
<location>
<position position="1707"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="1726"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by CARM1; alternate" evidence="68">
<location>
<position position="2142"/>
</location>
</feature>
<feature type="modified residue" description="Citrulline; by PADI4; alternate" evidence="68">
<location>
<position position="2142"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate">
<location>
<position position="1020"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate">
<location>
<position position="1024"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2230111." id="VAR_055554">
<original>M</original>
<variation>V</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample." id="VAR_014428" evidence="25">
<original>L</original>
<variation>P</variation>
<location>
<position position="827"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs20551." id="VAR_020425">
<original>I</original>
<variation>V</variation>
<location>
<position position="997"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample." id="VAR_014429" evidence="25">
<original>E</original>
<variation>G</variation>
<location>
<position position="1013"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_074021" evidence="96">
<original>N</original>
<variation>I</variation>
<location>
<position position="1511"/>
</location>
</feature>
<feature type="sequence variant" description="In a pancreatic cancer sample." id="VAR_014430" evidence="25">
<original>S</original>
<variation>Y</variation>
<location>
<position position="1650"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5758252." id="VAR_038376">
<original>T</original>
<variation>S</variation>
<location>
<position position="2174"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample; dbSNP:rs28937578." id="VAR_014431" evidence="25">
<original>P</original>
<variation>Q</variation>
<location>
<position position="2221"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1046088." id="VAR_038377" evidence="105">
<original>Q</original>
<variation>P</variation>
<location>
<position position="2223"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes AMPK-mediated phosphorylation." evidence="37">
<original>S</original>
<variation>A</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="mutagenesis site" description="Phosphomimetic mutant that leads to descreased interaction with nuclear receptors." evidence="37">
<original>S</original>
<variation>D</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with HIF1A and transcription activation; when associated with A-345." evidence="54">
<original>L</original>
<variation>A</variation>
<location>
<position position="344"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with HIF1A and transcription activation; when associated with A-344." evidence="54">
<original>L</original>
<variation>A</variation>
<location>
<position position="345"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with HIF1A. Reduces interaction with CITED2." evidence="112">
<original>TMKNVL</original>
<variation>NAAIRS</variation>
<location>
<begin position="371"/>
<end position="376"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with HIF1A. Does not inhibit interaction with CITED2." evidence="112">
<original>VCLPLK</original>
<variation>NAAIRS</variation>
<location>
<begin position="413"/>
<end position="418"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes sumoylation and transcriptional repression when associated with A-1024." evidence="52 66">
<original>K</original>
<variation>A</variation>
<location>
<position position="1020"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes sumoylation and transcriptional repression; when associated with R-1024." evidence="52 66">
<original>K</original>
<variation>R</variation>
<location>
<position position="1020"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes sumoylation and transcriptional repression; when associated with A-1020." evidence="52 66">
<original>K</original>
<variation>A</variation>
<location>
<position position="1024"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes sumoylation and transcriptional repression; when associated with R-1020." evidence="52 66">
<original>K</original>
<variation>R</variation>
<location>
<position position="1024"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased acetyltransferase activity." evidence="91">
<original>F</original>
<variation>E</variation>
<location>
<position position="1170"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased acetyltransferase activity." evidence="91">
<original>C</original>
<variation>R</variation>
<location>
<position position="1204"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased acetyltransferase activity." evidence="91">
<original>E</original>
<variation>K</variation>
<location>
<position position="1242"/>
</location>
</feature>
<feature type="mutagenesis site" description="40% decrease in activity." evidence="80">
<original>T</original>
<variation>L</variation>
<location>
<position position="1357"/>
</location>
</feature>
<feature type="mutagenesis site" description="40% decrease in activity. 90% decrease in activity; when associated with R-1505; R-1625 and R-1628." evidence="80">
<original>T</original>
<variation>R</variation>
<location>
<position position="1357"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity; when associated with R-1397." evidence="80">
<original>S</original>
<variation>R</variation>
<location>
<position position="1396"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity; when associated with W-1396." evidence="80">
<original>S</original>
<variation>W</variation>
<location>
<position position="1396"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity; when associated with R-1396." evidence="80">
<original>Y</original>
<variation>R</variation>
<location>
<position position="1397"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity; when associated with W-1397." evidence="80">
<original>Y</original>
<variation>W</variation>
<location>
<position position="1397"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes autoacetylation. Does not interact with TFAP2A and inhibits transcriptional coactivation of TFAP2A by CITED2. Does not inhibit interaction with CITED2, DNA-binding of TFAP2A or nuclear localization of TFAP2A or CITED2. No enhancement of FOXO1-mediated transcriptional activity. No inhibition of insulin-mediated translocation to the cytoplasm." evidence="51 69 91">
<original>D</original>
<variation>Y</variation>
<location>
<position position="1399"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes autoacetylation. Loss of acetyltransferase activity." evidence="91">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1467"/>
</location>
</feature>
<feature type="mutagenesis site" description="90% decrease in activity; when associated with R-1625 and R-1628. 90% decrease in activity; when associated with R-1357; R-1625 and R-1628." evidence="80">
<original>E</original>
<variation>R</variation>
<location>
<position position="1505"/>
</location>
</feature>
<feature type="mutagenesis site" description="70% decrease in activity; when associated with R-1628. 90% decrease in activity; when associated with R-1505 and R-1628. 90% decrease in activity; when associated with R-1357; R-1505 and R-1628." evidence="80">
<original>D</original>
<variation>R</variation>
<location>
<position position="1625"/>
</location>
</feature>
<feature type="mutagenesis site" description="70% decrease in activity; when associated with R-1625. 90% decrease in activity; when associated with E-1505 and R-1625. 90% decrease in activity; when associated with R-1357; R-1505 and R-1625." evidence="80">
<original>D</original>
<variation>R</variation>
<location>
<position position="1628"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased acetyltransferase activity." evidence="91">
<original>RR</original>
<variation>EE</variation>
<location>
<begin position="1645"/>
<end position="1646"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with NCOA2." evidence="68">
<original>R</original>
<variation>K</variation>
<location>
<position position="2056"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with NCOA2." evidence="68">
<original>R</original>
<variation>K</variation>
<location>
<position position="2088"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces interaction with NCOA2." evidence="68">
<original>R</original>
<variation>K</variation>
<location>
<position position="2142"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA18639." ref="1" evidence="113">
<original>M</original>
<variation>T</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA18639." ref="1" evidence="113">
<original>N</original>
<variation>D</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA18639." ref="1" evidence="113">
<original>T</original>
<variation>N</variation>
<location>
<position position="928"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA18639." ref="1" evidence="113">
<original>A</original>
<variation>T</variation>
<location>
<position position="1924"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="332"/>
<end position="334"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="335"/>
<end position="355"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="356"/>
<end position="358"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="367"/>
<end position="379"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="386"/>
<end position="389"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="391"/>
<end position="405"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="408"/>
<end position="410"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="414"/>
<end position="418"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="1051"/>
<end position="1066"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="1069"/>
<end position="1072"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="1073"/>
<end position="1075"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="1081"/>
<end position="1084"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="1089"/>
<end position="1092"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="1099"/>
<end position="1107"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="1114"/>
<end position="1131"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="1137"/>
<end position="1160"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="1165"/>
<end position="1168"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="1182"/>
<end position="1190"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="1195"/>
<end position="1197"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="1198"/>
<end position="1205"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="1208"/>
<end position="1216"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1218"/>
<end position="1221"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="1225"/>
<end position="1245"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="1248"/>
<end position="1250"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="1255"/>
<end position="1257"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="1264"/>
<end position="1272"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="1273"/>
<end position="1278"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="1290"/>
<end position="1292"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1297"/>
<end position="1313"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1321"/>
<end position="1334"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="1336"/>
<end position="1338"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1339"/>
<end position="1342"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="1343"/>
<end position="1347"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1351"/>
<end position="1366"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1369"/>
<end position="1381"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1392"/>
<end position="1400"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1407"/>
<end position="1409"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1410"/>
<end position="1428"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1432"/>
<end position="1436"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1446"/>
<end position="1450"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="1453"/>
<end position="1456"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1460"/>
<end position="1476"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="1478"/>
<end position="1480"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1482"/>
<end position="1485"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1486"/>
<end position="1493"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1498"/>
<end position="1500"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1508"/>
<end position="1517"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1582"/>
<end position="1590"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1592"/>
<end position="1594"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1595"/>
<end position="1601"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1603"/>
<end position="1606"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1622"/>
<end position="1624"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1625"/>
<end position="1627"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1628"/>
<end position="1636"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1644"/>
<end position="1662"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1726"/>
<end position="1728"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="1730"/>
<end position="1747"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="1756"/>
<end position="1770"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="1774"/>
<end position="1778"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="1780"/>
<end position="1793"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1799"/>
<end position="1802"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="1806"/>
<end position="1818"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1L3E"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1P4Q"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2MZD"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3BIY"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3T92"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4BHW"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5BT3"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5KJ2"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5LKT"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5LKX"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="B2RWS6"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255"/>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00035"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00203"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00228"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00311"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01065"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10545121"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10700188"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10722728"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10733570"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10823961"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11073989"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11073990"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11080476"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11349124"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11430825"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11433299"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11463834"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11481323"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11518699"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11559821"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11564735"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11581164"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11581372"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11701890"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11744733"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11864910"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11909954"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11959990"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11997499"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12402037"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12446687"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12527917"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12586840"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12718889"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12750254"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12778114"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12837748"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12929931"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14605447"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14645221"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14716005"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14752053"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15004546"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15075319"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15186775"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15297880"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15509808"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15632193"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15706485"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15731352"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15890677"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16478997"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16574662"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16617102"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16762839"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16809611"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16864582"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17065153"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17226766"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17267393"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17872950"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18273021"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18695000"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18722353"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18995842"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19217391"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19680224"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20081228"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21030595"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23145062"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23415232"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23911289"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23934153"/>
</source>
</evidence>
<evidence key="92" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23999430"/>
</source>
</evidence>
<evidence key="93" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24177535"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24382891"/>
</source>
</evidence>
<evidence key="95" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24413532"/>
</source>
</evidence>
<evidence key="96" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24476420"/>
</source>
</evidence>
<evidence key="97" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24819397"/>
</source>
</evidence>
<evidence key="98" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24939902"/>
</source>
</evidence>
<evidence key="99" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25219498"/>
</source>
</evidence>
<evidence key="100" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25245946"/>
</source>
</evidence>
<evidence key="101" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25818647"/>
</source>
</evidence>
<evidence key="102" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26479788"/>
</source>
</evidence>
<evidence key="103" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27189267"/>
</source>
</evidence>
<evidence key="104" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27959755"/>
</source>
</evidence>
<evidence key="105" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7523245"/>
</source>
</evidence>
<evidence key="106" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8684459"/>
</source>
</evidence>
<evidence key="107" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8917528"/>
</source>
</evidence>
<evidence key="108" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8945521"/>
</source>
</evidence>
<evidence key="109" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9528808"/>
</source>
</evidence>
<evidence key="110" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9590696"/>
</source>
</evidence>
<evidence key="111" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9862959"/>
</source>
</evidence>
<evidence key="112" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9887100"/>
</source>
</evidence>
<evidence key="113" type="ECO:0000305"/>
<evidence key="114" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20955178"/>
</source>
</evidence>
<sequence length="2414" mass="264161" checksum="8E869E1F174A6FEB" modified="2009-02-10" version="2">
MAENVVEPGPPSAKRPKLSSPALSASASDGTDFGSLFDLEHDLPDELINSTELGLTNGGD
INQLQTSLGMVQDAASKHKQLSELLRSGSSPNLNMGVGGPGQVMASQAQQSSPGLGLINS
MVKSPMTQAGLTSPNMGMGTSGPNQGPTQSTGMMNSPVNQPAMGMNTGMNAGMNPGMLAA
GNGQGIMPNQVMNGSIGAGRGRQNMQYPNPGMGSAGNLLTEPLQQGSPQMGGQTGLRGPQ
PLKMGMMNNPNPYGSPYTQNPGQQIGASGLGLQIQTKTVLSNNLSPFAMDKKAVPGGGMP
NMGQQPAPQVQQPGLVTPVAQGMGSGAHTADPEKRKLIQQQLVLLLHAHKCQRREQANGE
VRQCNLPHCRTMKNVLNHMTHCQSGKSCQVAHCASSRQIISHWKNCTRHDCPVCLPLKNA
GDKRNQQPILTGAPVGLGNPSSLGVGQQSAPNLSTVSQIDPSSIERAYAALGLPYQVNQM
PTQPQVQAKNQQNQQPGQSPQGMRPMSNMSASPMGVNGGVGVQTPSLLSDSMLHSAINSQ
NPMMSENASVPSLGPMPTAAQPSTTGIRKQWHEDITQDLRNHLVHKLVQAIFPTPDPAAL
KDRRMENLVAYARKVEGDMYESANNRAEYYHLLAEKIYKIQKELEEKRRTRLQKQNMLPN
AAGMVPVSMNPGPNMGQPQPGMTSNGPLPDPSMIRGSVPNQMMPRITPQSGLNQFGQMSM
AQPPIVPRQTPPLQHHGQLAQPGALNPPMGYGPRMQQPSNQGQFLPQTQFPSQGMNVTNI
PLAPSSGQAPVSQAQMSSSSCPVNSPIMPPGSQGSHIHCPQLPQPALHQNSPSPVPSRTP
TPHHTPPSIGAQQPPATTIPAPVPTPPAMPPGPQSQALHPPPRQTPTPPTTQLPQQVQPS
LPAAPSADQPQQQPRSQQSTAASVPTPTAPLLPPQPATPLSQPAVSIEGQVSNPPSTSST
EVNSQAIAEKQPSQEVKMEAKMEVDQPEPADTQPEDISESKVEDCKMESTETEERSTELK
TEIKEEEDQPSTSATQSSPAPGQSKKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVD
PQLLGIPDYFDIVKSPMDLSTIKRKLDTGQYQEPWQYVDDIWLMFNNAWLYNRKTSRVYK
YCSKLSEVFEQEIDPVMQSLGYCCGRKLEFSPQTLCCYGKQLCTIPRDATYYSYQNRYHF
CEKCFNEIQGESVSLGDDPSQPQTTINKEQFSKRKNDTLDPELFVECTECGRKMHQICVL
HHEIIWPAGFVCDGCLKKSARTRKENKFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGE
VTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQE
YGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPP
SEGDDYIFHCHPPDQKIPKPKRLQEWYKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKE
LPYFEGDFWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKNAKKKNNKKTSKNK
SSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIP
CDLMDGRDAFLTLARDKHLEFSSLRRAQWSTMCMLVELHTQSQDRFVYTCNECKHHVETR
WHCTVCEDYDLCITCYNTKNHDHKMEKLGLGLDDESNNQQAAATQSPGDSRRLSIQRCIQ
SLVHACQCRNANCSLPSCQKMKRVVQHTKGCKRKTNGGCPICKQLIALCCYHAKHCQENK
CPVPFCLNIKQKLRQQQLQHRLQQAQMLRRRMASMQRTGVVGQQQGLPSPTPATPTTPTG
QQPTTPQTPQPTSQPQPTPPNSMPPYLPRTQAAGPVSQGKAAGQVTPPTPPQTAQPPLPG
PPPAAVEMAMQIQRAAETQRQMAHVQIFQRPIQHQMPPMTPMAPMGMNPPPMTRGPSGHL
EPGMGPTGMQQQPPWSQGGLPQPQQLQSGMPRPAMMSVAQHGQPLNMAPQPGLGQVGISP
LKPGTVSQQALQNLLRTLRSPSSPLQQQQVLSILHANPQLLAAFIKQRAAKYANSNPQPI
PGQPGMPQGQPGLQPPTMPGQQGVHSNPAMQNMNPMQAGVQRAGLPQQQPQQQLQPPMGG
MSPQAQQMNMNHNTMPSQFRDILRRQQMMQQQQQQGAGPGIGPGMANHNQFQQPQGVGYP
PQQQQRMQHHMQQMQQGNMGQIGQLPQALGAEAGASLQAYQQRLLQQQMGSPVQPNPMSP
QQHMLPNQAQSPHLQGQQIPNSLSNQVRSPQPVPSPRPQSQPPHSSPSPRMQPQPSPHHV
SPQTSSPHPGLVAAQANPMEQGHFASPDQNSMLSQLASNPGMANLHGASATDLGLSTDNS
DLNSNLSQSTLDIH
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>